BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hu T, Li Z, Gao CY, Cho CH. Mechanisms of drug resistance in colon cancer and its therapeutic strategies. World J Gastroenterol 2016; 22(30): 6876-6889 [PMID: 27570424 DOI: 10.3748/wjg.v22.i30.6876]
URL: https://www.wjgnet.com/1007-9327/full/v22/i30/6876.htm
Number Citing Articles
1
Jing Liang, Xiao-Feng Tian, Wei Yang. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137World Journal of Gastroenterology 2020; 26(13): 1474-1489 doi: 10.3748/wjg.v26.i13.1474
2
Aditya Kumar, Yashika Uniyal, Roshan Kumar. Recent Advancement of Colorectal Cancer and Their Herbal Essential Oil TreatmentJournal for Research in Applied Sciences and Biotechnology 2022; 1(5) doi: 10.55544/jrasb.1.5.15
3
Morvarid Siri, Hamid Behrouj, Sanaz Dastghaib, Mozhdeh Zamani, Wirginia Likus, Sedigheh Rezaie, Jacek Hudecki, Saeed Khazayel, Marek J. Łos, Pooneh Mokarram, Saeid Ghavami. Casein Kinase-1-Alpha Inhibitor (D4476) Sensitizes Microsatellite Instable Colorectal Cancer Cells to 5-Fluorouracil via Authophagy Flux InhibitionArchivum Immunologiae et Therapiae Experimentalis 2021; 69(1) doi: 10.1007/s00005-021-00629-2
4
Simona-Ruxandra Volovat, Iolanda Augustin, Daniela Zob, Diana Boboc, Florin Amurariti, Constantin Volovat, Cipriana Stefanescu, Cati Raluca Stolniceanu, Manuela Ciocoiu, Eduard Alexandru Dumitras, Mihai Danciu, Delia Gabriela Ciobanu Apostol, Vasile Drug, Sinziana Al Shurbaji, Lucia-Georgiana Coca, Florin Leon, Adrian Iftene, Paul-Corneliu Herghelegiu. Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AICancers 2022; 14(19) doi: 10.3390/cancers14194834
5
Huan Liu, Guifang Li, Chenjie Shen, Xiaowei Qi, Yankui Liu, Dong Hua, Yong Mao, Ting Zhang. B7-H3-mediated deubiquitination stabilizing CYP1B1 expression promotes chemotherapy resistance in colorectal cancerBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2025; 1871(5) doi: 10.1016/j.bbadis.2025.167771
6
Like Zhong, Junfeng Zhu, Qi Shu, Gaoqi Xu, Chaoneng He, Luo Fang, Yanqing Liu. A Prognostic Cuproptosis-Related LncRNA Signature for Colon AdenocarcinomaJournal of Oncology 2023; 2023 doi: 10.1155/2023/5925935
7
Fei Wang, Dinglan Wu, Jianxiang Chen, Shiliang Chen, Fengrong He, Housheng Fu, Qinghui Wu, Shuan Liu, Xionggen Li, Weifu Wang. Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b/Smad2 axisExperimental Cell Research 2019; 375(1) doi: 10.1016/j.yexcr.2018.11.005
8
Li‐guang Yang, Ming‐zheng Cao, Jie Zhang, Xiao‐yan Li, Qin‐li Sun. LncRNA XIST modulates HIF‐1A/AXL signaling pathway by inhibiting miR‐93‐5p in colorectal cancerMolecular Genetics & Genomic Medicine 2020; 8(4) doi: 10.1002/mgg3.1112
9
Sheng Zhang, Treena Chatterjee, Carla Godoy, Ling Wu, Qingyun J. Liu, Kendra S. Carmon. GPR56 Drives Colorectal Tumor Growth and Promotes Drug Resistance through Upregulation of MDR1 Expression via a RhoA-Mediated MechanismMolecular Cancer Research 2019; 17(11) doi: 10.1158/1541-7786.MCR-19-0436
10
Ashraf N. Abdalla, Waleed H. Malki, Amal Qattan, Imran Shahid, Mohammad Akbar Hossain, Muhammad Ahmed. Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal CancerMolecules 2021; 26(2) doi: 10.3390/molecules26020334
11
Zili Gu, Jie Yin, Candido G. Da Silva, Qi Liu, Luis J. Cruz, Ferry Ossendorp, Ewa Snaar-Jagalska. Therapeutic liposomal combination to enhance chemotherapy response and immune activation of tumor microenvironmentJournal of Controlled Release 2024; 373 doi: 10.1016/j.jconrel.2024.07.015
12
Lyudmila Ounpuu, Laura Truu, Igor Shevchuk, Vladimir Chekulayev, Aleksandr Klepinin, Andre Koit, Kersti Tepp, Marju Puurand, Egle Rebane-Klemm, Tuuli Käämbre. Comparative analysis of the bioenergetics of human adenocarcinoma Caco-2 cell line and postoperative tissue samples from colorectal cancer patientsBiochemistry and Cell Biology 2018; 96(6) doi: 10.1139/bcb-2018-0076
13
Yi-Ling Jiang, Xue Li, Ya-Wen Tan, Yu-Jing Fang, Kai-Yan Liu, Yi-Fan Wang, Ting Ma, Qing-Jian Ou, Cai-Xia Zhang. Docosahexaenoic acid inhibits the invasion and migration of colorectal cancer by reversing EMT through the TGF-β1/Smad signaling pathwayFood & Function 2024; 15(18) doi: 10.1039/D4FO02346C
14
Sara Shamekhi, Jalal Abdolalizadeh, Alireza Ostadrahimi, Seyyed Abolghasem Mohammadi, Abolfazl Barzegari, Hajie Lotfi, Esat Bonabi, Nosratollah Zarghami. Apoptotic Effect of Saccharomyces cerevisiae on Human Colon Cancer SW480 Cells by Regulation of Akt/NF-ĸB Signaling PathwayProbiotics and Antimicrobial Proteins 2020; 12(1) doi: 10.1007/s12602-019-09528-7
15
Giulia Lori, Paolo Paoli, Angelo Pietro Femia, Erica Pranzini, Anna Caselli, Katia Tortora, Andrea Romagnoli, Giovanni Raugei, Giovanna Caderni. Morin‐dependent inhibition of low molecular weight protein tyrosine phosphatase (LMW‐PTP) restores sensitivity to apoptosis during colon carcinogenesis: Studies in vitro and in vivo, in an Apc‐driven model of colon cancerMolecular Carcinogenesis 2019; 58(5) doi: 10.1002/mc.22962
16
Winnie Fong, Kenneth K. W. To. Drug repurposing to overcome resistance to various therapies for colorectal cancerCellular and Molecular Life Sciences 2019; 76(17) doi: 10.1007/s00018-019-03134-0
17
Zhuo Wu, Su Zhou, Dan Liang, Lan Mu. GPX2 acts as an oncogene and cudraflavone C has an anti-tumor effect by suppressing GPX2-dependent Wnt/β-catenin pathway in colorectal cancer cellsNaunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(2) doi: 10.1007/s00210-023-02668-2
18
Lijun Ma, Fangfang Ai, Hongyan Xiao, Fang Wang, Lei Shi, Xuehong Bai, Yongzhao Zhu, Wenping Ma. Lycium barbarum polysaccharide reverses drug resistance in oxaliplatin-resistant colon cancer cells by inhibiting PI3K/AKT-dependent phosphomannose isomeraseFrontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1367747
19
Raghvendra Pandey, Prashant Kumar Singh, Alok Kumar Shrivastava. Colon Cancer Diagnosis and Therapy2021;  doi: 10.1007/978-3-030-64668-4_13
20
Ping Li, Chun-Feng Feng, Peng-Fei Lyu, Fei Liu, Hui-Sheng Li, Li-Qun Zhang. Three-in-one DNA nanowheels for simultaneous tumor regression and drug resistance prevention in breast cancer modelAdvanced Sensor and Energy Materials 2024; 3(3) doi: 10.1016/j.asems.2024.100104
21
WEI HU, THOMAS WARTMANN, MARCO STRECKER, ARISTOTELIS PERRAKIS, ROLAND CRONER, ARPAD SZALLASI, WENJIE SHI, ULF D. KAHLERT. Transient receptor potential channels as predictive marker and potential indicator of chemoresistance in colon cancerOncology Research 2024; 32(1) doi: 10.32604/or.2023.043053
22
Jianing Gong, Taoran Shi, Jinfeng Liu, Zerong Pei, Jingbo Liu, Xiaoliang Ren, Fengyun Li, Feng Qiu. Dual-drug codelivery nanosystems: An emerging approach for overcoming cancer multidrug resistanceBiomedicine & Pharmacotherapy 2023; 161 doi: 10.1016/j.biopha.2023.114505
23
Reza Seyyedi, Fereshteh Talebpour Amiri, Soghra Farzipour, Ehsan Mihandoust, Seyed Jalal Hosseinimehr. Mefenamic acid as a promising therapeutic medicine against colon cancer in tumor-bearing miceMedical Oncology 2022; 39(2) doi: 10.1007/s12032-021-01618-3
24
Ankur Sood, Atul Dev, Soni Jignesh Mohanbhai, Nishith Shrimali, Meena Kapasiya, Avinash Chandra Kushwaha, Subhasree Roy Choudhury, Prasenjit Guchhait, Surajit Karmakar. Disulfide-Bridged Chitosan-Eudragit S-100 Nanoparticles for Colorectal CancerACS Applied Nano Materials 2019; 2(10) doi: 10.1021/acsanm.9b01377
25
Kha Wai Hon, Nadiah Abu, Nurul-Syakima Ab Mutalib, Rahman Jamal. miRNAs and lncRNAs as Predictive Biomarkers of Response to FOLFOX Therapy in Colorectal CancerFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00846
26
Ali Khalafizadeh, Seyedeh Donya Hashemizadegan, Fatemeh Shokri, Babak Bakhshinejad, Keyvan Jabbari, Mahsa Motavaf, Sadegh Babashah. Competitive endogenous RNA networks: Decoding the role of long non‐coding RNAs and circular RNAs in colorectal cancer chemoresistanceJournal of Cellular and Molecular Medicine 2024; 28(7) doi: 10.1111/jcmm.18197
27
P. Vasudeva Raju, RamaRao Malla. Colon Cancer Diagnosis and Therapy Vol. 32022;  doi: 10.1007/978-3-030-72702-4_2
28
Sameena Gul, Muhammad Faisal Maqbool, Amara Maryam, Muhammad Khan, Hafiz Abdullah Shakir, Muhammad Irfan, Chaman Ara, Yongming Li, Tonghui Ma. Vitamin K: A novel cancer chemosensitizerBiotechnology and Applied Biochemistry 2022; 69(6) doi: 10.1002/bab.2312
29
Qingmei Ye, Xin Zhou, Han Ren, Fangxuan Han, Rong Lin, Juan Li. An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectivesFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1274336
30
Xilong Qian, Ying Wang, Zheng Liu, Fang Fang, Yulu Ma, Liu Zhou, Yanqiong Pan, Xiangsong Meng, Baofei Yan, Xingyu Zhu, Xiuxiu Wang, Jing Zhao, Shengjin Liu. Establishment of XRD fourier fingerprint identification method of realgar decoction pieces and its anti-tumor activity in tumor-in-situ transplanted miceJournal of Ethnopharmacology 2024; 331 doi: 10.1016/j.jep.2024.118303
31
Shiyi Chen, Qian Li, Wei Zheng. Multiomics analyses of human colorectal cancer reveal changes in mitochondrial metabolism associated with chemotherapy resistanceFrontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1625797
32
Saeedeh Keyvani‐Ghamsari, Khatereh Khorsandi, Asma Gul. Curcumin effect on cancer cells' multidrug resistance: An updatePhytotherapy Research 2020; 34(10) doi: 10.1002/ptr.6703
33
Rohitas Deshmukh. Modulation of Intestinal Flora as an Emerging Therapeutic Approach for the Treatment of Colon CancerCurrent Cancer Therapy Reviews 2025; 21(7) doi: 10.2174/0115733947302126240924050845
34
Folic acid-chitosan functionalized polymeric nanocarriers to treat colon cancerInternational Journal of Biological Macromolecules 2023; 253 doi: 10.1016/j.ijbiomac.2023.127142
35
Sun-Ji Park, Sung-Woo Lee, Heegyum Moon, Su-Min Jung, Jin-Man Kim, Dong-Seok Lee, Eui-Hwan Choi. Amphiregulin drives EGFR-dependent genome stability in colorectal cancer and represents a targetable vulnerabilityOncogene 2026; 45(29) doi: 10.1038/s41388-026-03850-5
36
Zhenyu Xu, Lu Chen, Zhangang Xiao, Yanhong Zhu, Hui Jiang, Yan Jin, Cheng Gu, Yilai Wu, Lin Wang, Wen Zhang, Jian Zuo, Dexi Zhou, Jiajie Luan, Jing Shen. Potentiation of the anticancer effect of doxorubicinin drug-resistant gastric cancer cells by tanshinone IIAPhytomedicine 2018; 51 doi: 10.1016/j.phymed.2018.05.012
37
Fatemeh Firouzi Amoodizaj, Sevda Baghaeifar, Elham Taheri, Mahdieh Farhoudi Sefidan Jadid, Maryam Safi, Nasrin Seyyed Sani, Saba Hajazimian, Alireza Isazadeh, Dariush Shanehbandi. RETRACTED: Enhanced anticancer potency of doxorubicin in combination with curcumin in gastric adenocarcinomaJournal of Biochemical and Molecular Toxicology 2020; 34(6) doi: 10.1002/jbt.22486
38
Ninon Very, Tony Lefebvre, Ikram El Yazidi-Belkoura. Drug resistance related to aberrant glycosylation in colorectal cancerOncotarget 2018; 9(1) doi: 10.18632/oncotarget.22377
39
Alessio Carmignani, Matteo Battaglini, Attilio Marino, Francesca Pignatelli, Gianni Ciofani. Drug-Loaded Polydopamine Nanoparticles for Chemo/Photothermal Therapy against Colorectal Cancer CellsACS Applied Bio Materials 2024; 7(4) doi: 10.1021/acsabm.3c01203
40
Yong Yang, Guoxin Wang, Dajian Zhu, Yanfeng Huang, Yong Luo, Pengfei Su, Xiaowu Chen, Qian Wang. Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancerInternational Journal of Oncology 2017; 51(2) doi: 10.3892/ijo.2017.4044
41
Dihydropyrimidinones: Recent Synthetic and Pharmacological Perspectives with Special Focus on Colon CancerJournal of Pharmaceutical Research and Development 2023;  doi: 10.47485/2694-5614.1017
42
Gülçin Yavuz Türel, Nilüfer Şahin Calapoğlu, Dilek Bayram, Meltem Özgöçmen, Vehbi Atahan Toğay, Eda Evgen Tülüceoğlu. Curcumin induces apoptosis through caspase dependent pathway in human colon carcinoma cellsMolecular Biology Reports 2022; 49(2) doi: 10.1007/s11033-021-06965-y
43
Pandian Sureshbabu Ram Kumar, Clayton Fernando Rencilin, Krishnan Sundar. Emerging nanomaterials for cancer immunotherapyExploration of Medicine 2021; 2(3) doi: 10.37349/emed.2021.00043
44
Shoumin Zhu, Shayan Khalafi, Zheng Chen, Julio Poveda, Dunfa Peng, Heng Lu, Mohammed Soutto, Jianwen Que, Monica Garcia-Buitrago, Alexander Zaika, Wael El-Rifai. Silencing of miR490–3p by H. pylori activates DARPP-32 and induces resistance to gefitinibCancer Letters 2020; 491 doi: 10.1016/j.canlet.2020.07.014
45
Yongchao Zhang, Zhuo-Xun Wu, Yuqi Yang, Jing-Quan Wang, Jun Li, Zoey Sun, Qiu-Xu Teng, Charles R. Ashby, Dong-Hua Yang. Poziotinib Inhibits the Efflux Activity of the ABCB1 and ABCG2 Transporters and the Expression of the ABCG2 Transporter Protein in Multidrug Resistant Colon Cancer CellsCancers 2020; 12(11) doi: 10.3390/cancers12113249
46
Xiang Li, Nan Wang, Yutong Wu, Yidan Liu, Ruoyu Wang. ALDH6A1 weakens the progression of colon cancer via modulating the RAS/RAF/MEK/ERK pathway in cancer cell linesGene 2022; 842 doi: 10.1016/j.gene.2022.146757
47
Roya Bazzaz, Hossain Bijanpour, Seyed M. B. Pirouzpanah, Parichehreh Yaghmaei, Nadereh Rashtchizadeh. Adjuvant therapy with γ‐tocopherol‐induce apoptosis in HT‐29 colon cancer via cyclin‐dependent cell cycle arrest mechanismJournal of Biochemical and Molecular Toxicology 2019; 33(11) doi: 10.1002/jbt.22399
48
Mahdi Shadnoush, Mehrnaz Momenan, Veronique Seidel, Sascha Tierling, Nayeralsadat Fatemi, Ehsan Nazemalhosseini-Mojarad, Mohammad Tayefeh Norooz, Makan Cheraghpour. A comprehensive update on the potential of curcumin to enhance chemosensitivity in colorectal cancerPharmacological Reports 2025; 77(1) doi: 10.1007/s43440-024-00652-y
49
Batool Fatima, Maryam Jamil, Dilshad Hussain, Adeela Saeed, Fahmida Jabeen, Muhammad Salman Sajid, Muhammad Najam-ul-Haq. Biochemistry of Drug Resistance2021;  doi: 10.1007/978-3-030-76320-6_13
50
Li-Li Yang, Meng Li, Wei Huang, Peng-Tao Ren, Qing-Hui Yan, Ying-Hao Hao. ANP32B promotes colorectal cancer cell progression and reduces cell sensitivity to PRAP1 inhibitor through up-regulating HPF1Heliyon 2024; 10(1) doi: 10.1016/j.heliyon.2023.e23829
51
Zheng Yang, Zhengye Liu, Mourboul Ablise, Aikebaier Maimaiti, Aizitiaili Aihaiti, Yusupuwajimu Alimujiang. Design and Synthesis of Novel α-Methylchalcone Derivatives, Anti-Cervical Cancer Activity, and Reversal of Drug Resistance in HeLa/DDP CellsMolecules 2023; 28(23) doi: 10.3390/molecules28237697
52
Ankur Sood, Aastha Gupta, Ravi Bharadwaj, Pavana Ranganath, Neal Silverman, Garima Agrawal. Biodegradable disulfide crosslinked chitosan/stearic acid nanoparticles for dual drug delivery for colorectal cancerCarbohydrate Polymers 2022; 294 doi: 10.1016/j.carbpol.2022.119833
53
Xiaoqing Wang, Meili Xi, Xing Lu, Xiangshi Tan. The Role and Mechanism of Innate Immune Regulation in Overcoming Oxaliplatin Resistance and Enhancing Anti-Tumor Efficacy in Colorectal CancerPharmaceuticals 2025; 18(3) doi: 10.3390/ph18030317
54
Hedayat Hosseini, Amin Abbasi, Sahar Sabahi, Sousan Akrami, Arshid Yousefi-Avarvand. Assessing the Potential Biological Activities of Postbiotics Derived from Saccharomyces cerevisiae: An In Vitro StudyProbiotics and Antimicrobial Proteins 2024; 16(4) doi: 10.1007/s12602-023-10117-y
55
Janusz Matuszyk. MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapyMolecular Medicine 2022; 28(1) doi: 10.1186/s10020-022-00516-2
56
Borong Zhou, Zhongchao Mai, Ying Ye, Yanan Song, Miao Zhang, Xinlin Yang, Wei Xia, Xiaofeng Qiu. The role of PYCR1 in inhibiting 5-fluorouracil-induced ferroptosis and apoptosis through SLC25A10 in colorectal cancerHuman Cell 2022; 35(6) doi: 10.1007/s13577-022-00775-5
57
Xiaoke Gu, Yanfei Jiang, Yingying Qu, Jing Chen, Dingding Feng, Chenglin Li, Xiaoxing Yin. Synthesis and biological evaluation of bifendate derivatives bearing 6,7-dihydro-dibenzo[c,e]azepine scaffold as potential P-glycoprotein and tumor metastasis inhibitorsEuropean Journal of Medicinal Chemistry 2018; 145 doi: 10.1016/j.ejmech.2018.01.019
58
Monu Kumar Kashyap, Akash Ved, Rajiv Ratan Singh Yadav, Akhand Pratap Singh, Mahima Kushwaha, Karuna S. Shukla. The Cell Death and Signal Transduction Mechanisms in Colorectal Carcinogenesis: Recent AdvancesAnti-Cancer Agents in Medicinal Chemistry 2023; 23(12) doi: 10.2174/1871520623666230328144748
59
Steven Forsythe, Naren Mehta, Mahesh Devarasetty, Hemamylammal Sivakumar, William Gmeiner, Shay Soker, Konstantinos Votanopoulos, Aleksander Skardal. Development of a Colorectal Cancer 3D Micro-tumor Construct Platform From Cell Lines and Patient Tumor Biospecimens for Standard-of-Care and Experimental Drug ScreeningAnnals of Biomedical Engineering 2020; 48(3) doi: 10.1007/s10439-019-02269-2
60
Sanaz Naghizadeh, Behzad Mansoori, Ali Mohammadi, Ebrahim Sakhinia, Behzad Baradaran. Gene Silencing Strategies in Cancer Therapy: An Update for Drug ResistanceCurrent Medicinal Chemistry 2019; 26(34) doi: 10.2174/0929867325666180403141554
61
Ralph A. de Groot, Daan Reedijk, Quentin Faucher, Silvia M. Mihăilă, Rosalinde Masereeuw. Strategies for overcoming ABC transporter-mediated multidrug resistance in colorectal cancerAmerican Journal of Physiology-Cell Physiology 2025; 329(3) doi: 10.1152/ajpcell.00412.2025
62
Xitong Su, Lei Wu, Mingming Hu, Wenxiang Dong, Meng Xu, Peng Zhang. Glycyrrhizic acid: A promising carrier material for anticancer therapyBiomedicine & Pharmacotherapy 2017; 95 doi: 10.1016/j.biopha.2017.08.123
63
F.N.U. Aakash, Sunny Kumar, Aasta Kumari, F.N.U. Shweta, F.N.U. Rumela, F.N.U. Partab, Shivam Singla, Abida Parveen. Role of ETS2 gene in inflammatory bowel disease: A narrative reviewMedicine 2025; 104(36) doi: 10.1097/MD.0000000000044234
64
Siddarth Agrawal, Marta Woźniak, Mateusz Łuc, Sebastian Makuch, Ewa Pielka, Anil Kumar Agrawal, Joanna Wietrzyk, Joanna Banach, Andrzej Gamian, Monika Pizon, Piotr Ziółkowski. Insulin enhancement of the antitumor activity of chemotherapeutic agents in colorectal cancer is linked with downregulating PIK3CA and GRB2Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53145-x
65
Chao Yang, Shuoyang Huang, Fengyu Cao, Yongbin Zheng. Role of ferroptosis-related genes in prognostic prediction and tumor immune microenvironment in colorectal carcinomaPeerJ 2021; 9 doi: 10.7717/peerj.11745
66
Ming‑Zhen Wang, Cheng‑Zhi Qiu, Wai‑Shi Yu, Yan‑Ta Guo, Chun‑Xiao Wang, Zhi‑Xiong Chen. GOLPH3 expression promotes the resistance of HT29 cells to 5‑fluorouracil by activating multiple signaling pathwaysMolecular Medicine Reports 2017;  doi: 10.3892/mmr.2017.7877
67
Zhiming Shan, Na An, Jielin Qin, Junmei Yang, Hongqi Sun, Wei Yang. Long non-coding RNA Linc00675 suppresses cell proliferation and metastasis in colorectal cancer via acting on miR-942 and Wnt/β-catenin signalingBiomedicine & Pharmacotherapy 2018; 101 doi: 10.1016/j.biopha.2018.02.123
68
Mohammad Kashif. Gene expression profiling to uncover prognostic and therapeutic targets in colon cancer, combined with docking and dynamics studies to discover potent anticancer inhibitorComputational Biology and Chemistry 2025; 115 doi: 10.1016/j.compbiolchem.2025.108349
69
Korosh Morshedi, Sarina Borran, Mohammad Saeid Ebrahimi, Mohammad Jaber Masoud khooy, Zeynab Sadat Seyedi, Atefeh Amiri, Mohammad Abbasi‐Kolli, Maryam Fallah, Haroon Khan, Amirhossein Sahebkar, Hamed Mirzaei. Therapeutic effect of curcumin in gastrointestinal cancers: A comprehensive reviewPhytotherapy Research 2021; 35(9) doi: 10.1002/ptr.7119
70
Neha Yadav, Rohitas Deshmukh, Rupa Mazumder. Recent Review on Potentials of Saponins in the Regulation of Inflammation in Colon Cancer: Current Progress and Future ProspectsThe Natural Products Journal 2025; 15(5) doi: 10.2174/0122103155305824240607050942
71
Dongxin Tang, Zhu Yang, Fengxi Long, Li Luo, Bing Yang, Ruyi Zhu, Xianan Sang, Gang Cao. Inhibition of MALAT1 reduces tumor growth and metastasis and promotes drug sensitivity in colorectal cancerCellular Signalling 2019; 57 doi: 10.1016/j.cellsig.2019.01.013
72
Sona Vodenkova, Tomas Buchler, Klara Cervena, Veronika Veskrnova, Pavel Vodicka, Veronika Vymetalkova. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and futurePharmacology & Therapeutics 2020; 206 doi: 10.1016/j.pharmthera.2019.107447
73
Sara Cherradi, Véronique Garambois, Johanna Marines, Augusto Faria Andrade, Alexandra Fauvre, Olivia Morand, Manon Fargal, Ferial Mancouri, Adeline Ayrolles-Torro, Nadia Vezzo-Vié, Marta Jarlier, Gerald Loussaint, Steve Huvelle, Nicolas Joubert, Thibault Mazard, Céline Gongora, Philippe Pourquier, Florence Boissière-Michot, Maguy Del Rio. Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cellsCell & Bioscience 2023; 13(1) doi: 10.1186/s13578-023-01015-5
74
Hande Maden, Hilal Calik, Rabia Yilmaz Ozturk, Selcen Ari Yuka, Betül Zehra Temur, Özge Can, Gizem Dinler Doğanay, Rabia Cakir. In silico–designed peptide targeting MDR1 (P-gp) restores chemosensitivity in colorectal cancer via chitosan nanoparticle deliveryJournal of Drug Delivery Science and Technology 2026; 117 doi: 10.1016/j.jddst.2026.108003
75
Jesica M. Ramírez-Villalobos, César I. Romo-Sáenz, Karla S. Morán-Santibañez, Patricia Tamez-Guerra, Ramiro Quintanilla-Licea, Alonso A. Orozco-Flores, Ricardo Romero-Arguelles, Reyes Tamez-Guerra, Cristina Rodríguez-Padilla, Ricardo Gomez-Flores. In Vitro Tumor Cell Growth Inhibition Induced by Lophocereus marginatus (DC.) S. Arias and Terrazas Endophytic Fungi ExtractsInternational Journal of Environmental Research and Public Health 2021; 18(18) doi: 10.3390/ijerph18189917
76
Arunaksharan Narayanankutty. PI3K/ Akt/ mTOR Pathway as a Therapeutic Target for Colorectal Cancer: A Review of Preclinical and Clinical EvidenceCurrent Drug Targets 2019; 20(12) doi: 10.2174/1389450120666190618123846
77
Shan-Ju Yeh, Shuo-Wei Chen, Bor-Sen Chen. Investigation of the Genome-Wide Genetic and Epigenetic Networks for Drug Discovery Based on Systems Biology Approaches in Colorectal CancerFrontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00117
78
Narges Toolabi, Fattane Sam Daliri, Amir Mokhlesi, Mahmood Talkhabi. Identification of key regulators associated with colon cancer prognosis and pathogenesisJournal of Cell Communication and Signaling 2022; 16(1) doi: 10.1007/s12079-021-00612-8
79
Wanying Liao, Junyu Long, Yiran Li, Fucun Xie, Ziyu Xun, Yanyu Wang, Xu Yang, Yunchao Wang, Kang Zhou, Xinting Sang, Haitao Zhao. Identification of an m6A-Related Long Noncoding RNA Risk Model for Predicting Prognosis and Directing Treatments in Patients With Colon AdenocarcinomaFrontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.910749
80
Sanaz Salek, Elham Moazamian, Afshin Mohammadi Bardbori, Seyedeh Azra Shamsdin. Anticancer effect of a combinatorial treatment of 5-fluorouracil and cell extract of some probiotic lactobacilli strains isolated from camel milk on colorectal cancer cellsFolia Microbiologica 2025; 70(5) doi: 10.1007/s12223-024-01228-2
81
Di Wu, Wen-Yi Zhou, Xiao-Tong Lin, Lei Fang, Chuan-Ming Xie. Bufalin induces apoptosis via mitochondrial ROS-mediated caspase-3 activation in HCT-116 and SW620 human colon cancer cellsDrug and Chemical Toxicology 2019; 42(4) doi: 10.1080/01480545.2018.1512611
82
Janet Piloto-Ferrer, Ángel Sánchez-Lamar, Marbelis Francisco, Maria L. González, Nelsón Merino, Guillermo Aparicio, Carlos Pérez, Idania Rodeiro, Miriam Teresa Paz Lopes. Xanthium strumarium´s xanthatins induces mitotic arrest and apoptosis in CT26WT colon carcinoma cellsPhytomedicine 2019; 57 doi: 10.1016/j.phymed.2018.12.019
83
Dengfeng Hou, Zhongyuan Bai, Jiaxin Zhao, Haipeng Fan, Junsheng Chen, Wenqi Bai. Colorectal cancer-derived exosomal ETS2 promotes macrophage M2 polarization by transcriptionally activating PRPF4Human Cell 2026; 39(8) doi: 10.1007/s13577-026-01431-y
84
Marta Woźniak, Sebastian Makuch, Kinga Winograd, Jerzy Wiśniewski, Piotr Ziółkowski, Siddarth Agrawal. 6-Shogaol enhances the anticancer effect of 5-fluorouracil, oxaliplatin, and irinotecan via increase of apoptosis and autophagy in colon cancer cells in hypoxic/aglycemic conditionsBMC Complementary Medicine and Therapies 2020; 20(1) doi: 10.1186/s12906-020-02913-8
85
Tayo Alex Adekiya. Beyond Docetaxel: Targeting Resistance Pathways in Prostate Cancer TreatmentBioChem 2025; 5(3) doi: 10.3390/biochem5030024
86
Susmita Ghosh, Fan Fan, Reid T. Powell, Jason Roszik, Yong Sung Park, Clifford Stephan, Manu Sebastian, Lin Tan, Alexey V. Sorokin, Philip L. Lorenzi, Scott Kopetz, Lee M. Ellis, Rajat Bhattacharya. Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal CancerMolecular Cancer Therapeutics 2023; 22(8) doi: 10.1158/1535-7163.MCT-23-0110
87
Hend Al-Jaber, Kabir H. Biswas, Layla Al-Mansoori. Advancing targeted therapy for colorectal cancer: harnessing ligand-directed enzyme prodrug therapy for highly specific interventionsFrontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1570712
88
Ming Hu, Xiandong Fu, Zhaoming Si, Chunming Li, Jihu Sun, Xinna Du, Hu Zhang. Identification of Differently Expressed Genes Associated With Prognosis and Growth in Colon Adenocarcinoma Based on Integrated Bioinformatics AnalysisFrontiers in Genetics 2019; 10 doi: 10.3389/fgene.2019.01245
89
Chao Liu, Sheng Xu, Yuanyuan Liu, Yuntian Tang. RCC1 Domain‐Containing Protein 1 Promotes Colon Cancer Malignant Progression by Activating Autophagy‐Dependent WNT5A Secretion in Cancer‐Associated FibroblastsJournal of the Royal Society of New Zealand 2026; 56(1) doi: 10.1002/snz2.70013
90
Hang Li, Shaohong Lu, Yu Chen, Longzhi Zheng, Liangyuan Chen, Haojie Ding, Jianzu Ding, Di Lou, Fangfang Liu, Bin Zheng. AKT2 phosphorylation of hexokinase 2 at T473 promotes tumorigenesis and metastasis in colon cancer cells via NF-κB, HIF1α, MMP2, and MMP9 upregulationCellular Signalling 2019; 58 doi: 10.1016/j.cellsig.2019.03.011
91
Md. Sanower Hossain, Hidayah Karuniawati, Ammar Abdulrahman Jairoun, Zannat Urbi, Der Jiun Ooi, Akbar John, Ya Chee Lim, K. M. Kaderi Kibria, A.K. M. Mohiuddin, Long Chiau Ming, Khang Wen Goh, Muhammad Abdul Hadi. Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment StrategiesCancers 2022; 14(7) doi: 10.3390/cancers14071732
92
Rafael Moreno-Sánchez, Álvaro Marín-Hernández, Juan C. Gallardo-Pérez, Silvia C. Pacheco-Velázquez, Diana X. Robledo-Cadena, Joaquín Alberto Padilla-Flores, Emma Saavedra, Sara Rodríguez-Enríquez. Physiological Role of Glutamate Dehydrogenase in Cancer CellsFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00429
93
Keisuke Okuno, Muhammad Yogi Pratama, Jiang Li, Masanori Tokunaga, Xin Wang, Yusuke Kinugasa, Ajay Goel. Ginseng mediates its anticancer activity by inhibiting the expression of DNMTs and reactivating methylation-silenced genes in colorectal cancerCarcinogenesis 2023; 44(5) doi: 10.1093/carcin/bgad025
94
Tyler S. Larson, Gary L. Glish, Matthew R. Lockett. Spatially resolved quantification of drug metabolism and efficacy in 3D paper-based tumor mimicsAnalytica Chimica Acta 2021; 1186 doi: 10.1016/j.aca.2021.339091
95
Yushan Mao, Hanhan Xie, Dan Shu, Lin Cheng, Jingbin Lan, Kejian Pan. Moxidectin induces autophagy arrest in colorectal cancerMedical Oncology 2022; 39(12) doi: 10.1007/s12032-022-01799-5
96
Neelakanta Sarvashiva Kiran, Yogitha N. Sagar, Krishna Badrakiya, Ankita Chatterjee, Omar Awad Alsaidan, Sankha Bhattacharya, Bhupendra Prajapati. Phospholipid and triglyceride-based nanocomposites: A versatile approach for colon cancer – bridging basic science to translational applications in drug delivery and beyondJournal of Drug Delivery Science and Technology 2025; 114 doi: 10.1016/j.jddst.2025.107523
97
Yi Ji, Jialin Gu, Hongqun Zhang, Houxi Xu. Identification and Validation of Key miRNAs for Colon Cancer Based on miRNA-Gene Integration AnalysisInternational Journal of General Medicine 2023;  doi: 10.2147/IJGM.S440340
98
Arka Jyoti Chakraborty, Tanvir Mahtab Uddin, B. M. Redwan Matin Zidan, Saikat Mitra, Rajib Das, Firzan Nainu, Kuldeep Dhama, Arpita Roy, Md. Jamal Hossain, Ameer Khusro, Talha Bin Emran, Ruchika Garg. Allium cepa: A Treasure of Bioactive Phytochemicals with Prospective Health BenefitsEvidence-Based Complementary and Alternative Medicine 2022; 2022 doi: 10.1155/2022/4586318
99
Bishu Zhang, Jiewei Lin, Jiaqiang Zhang, Xuelong Wang, Xiaxing Deng. Integrated Chromatin Accessibility and Transcriptome Landscapes of 5-Fluorouracil-Resistant Colon Cancer CellsFrontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.838332
100
Yanwen Wang, Fa Si, Lei Huang, Zhengtai Li, Changyuan Yu. Machine Learning-Based Analysis of Large-Scale Transcriptomic Data Identifies Core Genes Associated with Multi-Drug ResistanceInternational Journal of Molecular Sciences 2026; 27(3) doi: 10.3390/ijms27031245
101
Jaeok Lee, Jiyeon Kang, Na-Yun Kwon, Aneesh Sivaraman, Ravi Naik, So-Young Jin, A. Reum Oh, Jae-Ho Shin, Younghwa Na, Kyeong Lee, Hwa-Jeong Lee. Dual Inhibition of P-gp and BCRP Improves Oral Topotecan Bioavailability in RodentsPharmaceutics 2021; 13(4) doi: 10.3390/pharmaceutics13040559
102
Rukeia El-Athman, Luise Fuhr, Angela Relógio. A Systems-Level Analysis Reveals Circadian Regulation of Splicing in Colorectal CancerEBioMedicine 2018; 33 doi: 10.1016/j.ebiom.2018.06.012
103
Mohammed Tanveer Ahmed, Sampa Sarkar, Ravi Shukla, Rajkumar Banerjee. Etoposide‐Entrapped Progesterone‐Cationic Lipid Nanoaggregates as Selective Therapeutics against Etoposide‐Resistant Colorectal Cancer CellsChemBioChem 2023; 24(12) doi: 10.1002/cbic.202200650
104
Laura Ioana Gavrilas, Daniel Cruceriu, Andrei Mocan, Felicia Loghin, Doina Miere, Ovidiu Balacescu. Plant-Derived Bioactive Compounds in Colorectal Cancer: Insights from Combined Regimens with Conventional Chemotherapy to Overcome Drug-ResistanceBiomedicines 2022; 10(8) doi: 10.3390/biomedicines10081948
105
Agustina Tri Endharti, Yeni Purnamasari, Renata Primasari, Sri Poeranto, Sofy Permana. Coelomic Fluid of Lumbricus rubellus Synergistically Enhances Cytotoxic Effect of 5-Fluorouracil through Modulation of Focal Adhesion Kinase and p21 in HT-29 Cancer Cell LineThe Scientific World Journal 2019; 2019 doi: 10.1155/2019/5632859
106
Amin Safa, Mina Shafiei, Arash Norouzpour Sangari, Asal Norouzi Roudbordeh, Fatemeh Ghaderibarmi, Mahdis Kohsarian, Reza Mohaghegh, Zahra Maleki Maaf, Mohadeseh Emamdoost Valisaraei, Zeinab Faraji, Ali Salehzadeh. Targeted anticancer effects of Juglone-ZnO nanoparticles via cell cycle arrest and caspase-mediated apoptosis in colon cancer cellsScientific Reports 2025; 16(1) doi: 10.1038/s41598-025-31183-y
107
Kinga Oravetz, Adelina-Violeta Todea, Ovidiu Balacescu, Daniel Cruceriu, Elena Rakosy-Tican. Potential antitumor activity of garlic against colorectal cancer: focus on the molecular mechanisms of actionEuropean Journal of Nutrition 2023; 62(6) doi: 10.1007/s00394-023-03166-0
108
Yeelon Yeoh, Teck Yew Low, Nadiah Abu, Pey Yee Lee. Regulation of signal transduction pathways in colorectal cancer: implications for therapeutic resistancePeerJ 2021; 9 doi: 10.7717/peerj.12338
109
Alejandro Javier Español, Yamila Sanchez, Sofia Volpi. Metronomic Chemotherapy Response in MDA-MB-231 Triple-Negative Breast Cancer Cells under Nicotine ExposureBIOCELL 2025; 49(8) doi: 10.32604/biocell.2025.068034
110
Tanusree Ray, Pinaki Roy, Niraj Nag, Animesh Gope, Amit Pal. Microtubule disruption and apoptotic induction by Vibrio cholerae haemagglutinin protease: Implications for anticancer therapy in colon and gastric tumoursThe Indian Journal of Medical Research 2026; 164 doi: 10.25259/IJMR_189_2026
111
Jie Zhang , Qianqian Song, Mengna Wu, Wenjie Zheng. The Emerging Roles of Exosomes in the Chemoresistance of Hepatocellular CarcinomaCurrent Medicinal Chemistry 2020; 28(1) doi: 10.2174/0929867327666200130103206
112
Mei Sun, Xiang Tian, Zhibo Yang. Microscale Mass Spectrometry Analysis of Extracellular Metabolites in Live Multicellular Tumor SpheroidsAnalytical Chemistry 2017; 89(17) doi: 10.1021/acs.analchem.7b01746
113
Yaiza Jiménez-Martínez, Carmen Griñán-Lisón, Hoda Khaldy, Ana Martín, Alba Cambrils, Andrea Ibáñez Grau, Gema Jiménez, Juan A. Marchal, Houria Boulaiz. LdrB Toxin with In Vitro and In Vivo Antitumor Activity as a Potential Tool for Cancer Gene TherapyCancers 2019; 11(7) doi: 10.3390/cancers11071016
114
Seyedeh Nasim Mirbahari, Nayeralsadat Fatemi, Sanaz Savabkar, Vahid Chaleshi, Neda Zali, Mohammad Yaghoob Taleghani, Ebrahim Mirzaei, Leili Rejali, Pardis Ketabi Moghadam, Ehsan Nazemalhosseini Mojarad. Unmasking early colorectal cancer clues: in silico and in vitro investigation of downregulated IGF2, SOCS1, MLH1, and CACNA1G in SSA polypsMolecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09683-3
115
Dan Wang, Li Yang, Weina Yu, Qian Wu, Jingyao Lian, Feng Li, Shasha Liu, Aitian Li, Zhiang He, Jinbo Liu, Zhenqiang Sun, Weitang Yuan, Yi Zhang. Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signalingJournal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0701-2
116
Musbau Adewumi Akanji, Heritage Demilade Fatinukun, Damilare Emmanuel Rotimi, Boluwatife Lawrence Afolabi, Oluyomi Stephen Adeyemi. Antioxidants - Benefits, Sources, Mechanisms of Action2021;  doi: 10.5772/intechopen.94988
117
Hyeon-Hui Ki, Ji-Hyun Lee, Hoon-Yeon Lee, Young-Mi Lee, Dae-Ki Kim. Triticum aestivum Sprouts Extract Inhibits Azoymethane (AOM)/Dextran Sodium Sulfate (DSS)-Induced Colon Carcinogenesis in Mice Nutrition and Cancer 2018; 70(6) doi: 10.1080/01635581.2018.1490447
118
Guangyi Liu, Huan Wang, Rui Ran, Yicheng Wang, Yang Li. FOSL1 transcriptionally regulates PHLDA2 to promote 5-FU resistance in colon cancer cellsPathology - Research and Practice 2023; 246 doi: 10.1016/j.prp.2023.154496
119
Lichao Zhang, Xiaoqing Lu, Yuanzhi Xu, Xiaoqin La, Jinmiao Tian, Aiping Li, Hanqing Li, Changxin Wu, Yanfeng Xi, Guisheng Song, Zhaocai Zhou, Wenqi Bai, Liwei An, Zhuoyu Li. Tumor-associated macrophages confer colorectal cancer 5-fluorouracil resistance by promoting MRP1 membrane translocation via an intercellular CXCL17/CXCL22–CCR4–ATF6–GRP78 axisCell Death & Disease 2023; 14(9) doi: 10.1038/s41419-023-06108-0
120
José L. Padilla Agudelo, Diego F. Rincón Reyes, Karen L. Pachón Meza, Andrea I. Pinilla Da Silva, Camilo Ernesto Moreno Cristancho, Nataly Cruz Rodriguez, José A. Gutiérrez Triana. ID1 gene overexpression confers quiescence and chemoresistance in a leukemia cellular modelGene Reports 2025; 38 doi: 10.1016/j.genrep.2024.102110
121
Xiao‑Yun Li, Xiao‑Feng Liao, Hong‑Bo Wang, Jian Zhang. Doxorubicin resistance induces IL6 activation in the colon cancer cell line LS180Oncology Letters 2018;  doi: 10.3892/ol.2018.9360
122
Hanbing Xu, Xingwang Xie, Jiantao Han, Chengpeng Zhang. miR-340 reverses chemotherapy resistance in colon cancer via the PDCD4/WNT/β-catenin signalling pathwayScientific Reports 2025; 15(1) doi: 10.1038/s41598-025-18832-y
123
Ana Luiza C. de S. L. Oliveira, Raimundo Fernandes de Araújo Júnior, Thaís Gomes de Carvalho, Alan B. Chan, Timo Schomann, Filippo Tamburini, Lioe-Fee de Geus-Oei, Luis J. Cruz. Effect of Oxaliplatin-Loaded Poly (d,l-Lactide-co-Glycolic Acid) (PLGA) Nanoparticles Combined with Retinoic Acid and Cholesterol on Apoptosis, Drug Resistance, and Metastasis Factors of Colorectal CancerPharmaceutics 2020; 12(2) doi: 10.3390/pharmaceutics12020193
124
Zi‐Ning Lei, Qiu‐Xu Teng, Zhuo‐Xun Wu, Feng‐Feng Ping, Peng Song, John N.D. Wurpel, Zhe‐Sheng Chen. Overcoming multidrug resistance by knockout of ABCB1 gene using CRISPR/Cas9 system in SW620/Ad300 colorectal cancer cellsMedComm 2021; 2(4) doi: 10.1002/mco2.106
125
Chao Chen, Lu Lu, Shichao Yan, Huimei Yi, Hui Yao, Di Wu, Guangchun He, Xiaojun Tao, Xiyun Deng. Autophagy and doxorubicin resistance in cancerAnti-Cancer Drugs 2018; 29(1) doi: 10.1097/CAD.0000000000000572
126
Cordula Stillhart, Katarina Vučićević, Patrick Augustijns, Abdul W. Basit, Hannah Batchelor, Talia R. Flanagan, Ina Gesquiere, Rick Greupink, Daniel Keszthelyi, Mikko Koskinen, Christine M. Madla, Christophe Matthys, Goran Miljuš, Miriam G. Mooij, Neil Parrott, Anna-Lena Ungell, Saskia N. de Wildt, Mine Orlu, Sandra Klein, Anette Müllertz. Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP reviewEuropean Journal of Pharmaceutical Sciences 2020; 147 doi: 10.1016/j.ejps.2020.105280
127
Yun Luo, Chong-Zhi Wang, Richard Sawadogo, Jinbin Yuan, Jinxiang Zeng, Ming Xu, Ting Tan, Chun-Su Yuan. 4-Vinylguaiacol, an Active Metabolite of Ferulic Acid by Enteric Microbiota and Probiotics, Possesses Significant Activities against Drug-Resistant Human Colorectal Cancer CellsACS Omega 2021; 6(7) doi: 10.1021/acsomega.0c04394
128
Yinghui Huang, Huiqian Huang, Yong Wang, Hui Liu, Yingdan Huang. 5mC-Related lncRNAs as Potential Prognostic Biomarkers in Colon AdenocarcinomaBiology 2022; 11(2) doi: 10.3390/biology11020231
129
Lubna Siddiqui, Nazeer Hasan, Pawan K. Mishra, Neha Gupta, Anu T. Singh, Alka Madaan, Manu Jaggi, Suma Saad, Adam Ekielski, Zeenat Iqbal, Prashant Kesharwani, Sushama Talegaonkar. CD44 mediated colon cancer targeting mutlifaceted lignin nanoparticles: Synthesis, in vitro characterization and in vivo efficacy studiesInternational Journal of Pharmaceutics 2023; 643 doi: 10.1016/j.ijpharm.2023.123270
130
Xing-Hua Zhou, Jian Kang, Zhen-Dong Zhong, Yue Cheng. Osthole induces apoptosis of the HT‑29 cells via endoplasmic reticulum stress and autophagyOncology Letters 2021; 22(4) doi: 10.3892/ol.2021.12987
131
Mark Primeaux, Zeina Nehme, Iram Fatima, Frank Jühling, Emilie Crouchet, Jade Brochon, Alberto Toso, Catherine Schuster, Amar B. Singh, Thomas F. Baumert, Punita Dhawan. Humanized anti-Claudin-1 antibodies to treat colorectal cancerOncogene 2026; 45(32) doi: 10.1038/s41388-026-03880-z
132
Samar Al Bitar, Marwan El-Sabban, Samer Doughan, Wassim Abou-Kheir. Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyondWorld Journal of Gastroenterology 2023; 29(9): 1395-1426 doi: 10.3748/wjg.v29.i9.1395
133
Piroonrat Dechbumroong, Runjing Hu, Wisawat Keaswejjareansuk, Katawut Namdee, Xing-Jie Liang. Recent advanced lipid-based nanomedicines for overcoming cancer resistanceCancer Drug Resistance 2024;  doi: 10.20517/cdr.2024.19
134
Hesham Haffez, Hend H. Sanad, Hassan Ebrahim, Zeineb A. Hassan. Synergistic effects of abietic acid combined with doxorubicin on apoptosis induction in a human colorectal cancer cell lineScientific Reports 2025; 15(1) doi: 10.1038/s41598-025-99616-2
135
Chien-Yu Huang, Po-Li Wei, Uyanga Batzorig, Precious Takondwa Makondi, Cheng-Chin Lee, Yu-Jia Chang. Identification of Moesin (MSN) as a Potential Therapeutic Target for Colorectal Cancer via the β-Catenin-RUNX2 AxisInternational Journal of Molecular Sciences 2023; 24(13) doi: 10.3390/ijms241310951
136
Cheng Chen, Ana Beloqui, Yining Xu. Oral nanomedicine biointeractions in the gastrointestinal tract in health and diseaseAdvanced Drug Delivery Reviews 2023; 203 doi: 10.1016/j.addr.2023.115117
137
Zhiwen Li, Xu Zhou, Huaqiang Zhu, Xie Song, Hengjun Gao, Zheyu Niu, Jun Lu. Purpurin binding interacts with LHPP protein that inhibits PI3K/AKT phosphorylation and induces apoptosis in colon cancer cells HCT‐116Journal of Biochemical and Molecular Toxicology 2021; 35(3) doi: 10.1002/jbt.22665
138
Jinjin Chu, Xianzhu Fang, Zhonghou Sun, Linlin Gai, Wenqing Dai, Haibo Li, Xinyi Yan, Jinke Du, Lili Zhang, Lu Zhao, Donghua Xu, Shushan Yan. Non-Coding RNAs Regulate the Resistance to Anti-EGFR Therapy in Colorectal CancerFrontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.801319
139
Marloes Zoetemelk, George M. Ramzy, Magdalena Rausch, Thibaud Koessler, Judy R. van Beijnum, Andrea Weiss, Valentin Mieville, Sander R. Piersma, Richard R. de Haas, Céline Delucinge‐Vivier, Axel Andres, Christian Toso, Alexander A. Henneman, Simone Ragusa, Tatiana V. Petrova, Mylène Docquier, Thomas A. McKee, Connie R. Jimenez, Youssef Daali, Arjan W. Griffioen, Laura Rubbia‐Brandt, Pierre‐Yves Dietrich, Patrycja Nowak‐Sliwinska. Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatmentMolecular Oncology 2020; 14(11) doi: 10.1002/1878-0261.12797
140
Francisco Quiñonero, Cristina Mesas, Mercedes Peña, Laura Cabeza, Gloria Perazzoli, Consolación Melguizo, Raul Ortiz, Jose Prados. Vegetal-Derived Bioactive Compounds as Multidrug Resistance Modulators in Colorectal CancerApplied Sciences 2023; 13(4) doi: 10.3390/app13042667
141
Anshul Panjeta, Simran Preet. Anticancer potential of human intestinal defensin 5 against 1, 2-dimethylhydrazine dihydrochloride induced colon cancer: A therapeutic approachPeptides 2020; 126 doi: 10.1016/j.peptides.2020.170263
142
Nada K. Sedky, Iten M. Fawzy, Afnan Hassan, Noha Khalil Mahdy, Reem T. Attia, Samir N. Shamma, Mohammad Y. Alfaifi, Serag Eldin Elbehairi, Fatma A. Mokhtar, Sherif Ashraf Fahmy. Innovative microwave-assisted biosynthesis of copper oxide nanoparticles loaded with platinum(ii) based complex for halting colon cancer: cellular, molecular, and computational investigationsRSC Advances 2024; 14(6) doi: 10.1039/D3RA08779D
143
Koniyan Shaheer, HM Somashekarappa, M. Divya Lakshmanan. Piperine sensitizes radiation‐resistant cancer cells towards radiation and promotes intrinsic pathway of apoptosisJournal of Food Science 2020; 85(11) doi: 10.1111/1750-3841.15496
144
Mingfei Liu, Yueling Yan, Shirong Li, Rongrong Wang, Kewu Zeng, Jingchun Yao. Multifaceted Attack Networks of Artemisinin in Reversing Chemoresistance in Colorectal CancerMolecules 2026; 31(2) doi: 10.3390/molecules31020244
145
Xiaobin Zhang, Qingshui Yang, Zongyu Liang, Zhu Li, Chunlei Lu, Mohammad Reza Kalhori. Identification of the SUMOylation Gene Signature in Colon Cancer by Transcriptome and Mendelian Randomization IntegrationEuropean Journal of Cancer Care 2025; 2025(1) doi: 10.1155/ecc/8659536
146
Negar Moradian, Nima Rezaei. Cancer and Targeting the Immune SystemHandbook of Cancer and Immunology 2025; 6 doi: 10.1007/978-3-032-00767-4_197
147
Junsha An, Cheng Peng, Hailin Tang, Xiuxiu Liu, Fu Peng. New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast CancerInternational Journal of Molecular Sciences 2021; 22(17) doi: 10.3390/ijms22179644
148
Arunaksharan Narayanankutty, Sreelakshmi Nambiattil, Sreeshna Mannarakkal. Phytochemicals and Nanoparticles in the Modulation of PI3K/Akt/mTOR Kinases and its Implications in the Development and Progression of Gastrointestinal Cancers: A Review of Preclinical and Clinical EvidenceRecent Patents on Anti-Cancer Drug Discovery 2023; 18(3) doi: 10.2174/1574892817666220606104712
149
Jiaoyu Yi, Bo Tao, Hao Chen, Nobuyuki Horita, Yong Xu. The mechanism of lactylation modification in the progression and drug resistance of lung cancer: A reviewCurrent Molecular Pharmacology 2026; 19(1) doi: 10.1016/j.cmp.2026.03.004
150
Julita Kulbacka, Nina Rembiałkowska, Anna Szewczyk, Helena Moreira, Anna Szyjka, Irutė Girkontaitė, Kamil P. Grela, Vitalij Novickij. The Impact of Extracellular Ca2+ and Nanosecond Electric Pulses on Sensitive and Drug-Resistant Human Breast and Colon Cancer CellsCancers 2021; 13(13) doi: 10.3390/cancers13133216
151
Atul Sudame, Ganeshlenin Kandasamy, Deepak Singh, C.V. Tomy, Dipak Maity. Symbiotic thermo-chemotherapy for enhanced HepG2 cancer treatment via magneto-drugs encapsulated polymeric nanocarriersColloids and Surfaces A: Physicochemical and Engineering Aspects 2020; 606 doi: 10.1016/j.colsurfa.2020.125355
152
Yan-Jie Xu, Jie-Min Zhao, Cao Gao, Xue-Feng Ni, Wei Wang, Wen-Wei Hu, Chang-Ping Wu. Hsa_circ_0136666 activates Treg-mediated immune escape of colorectal cancer via miR-497/PD-L1 pathwayCellular Signalling 2021; 86 doi: 10.1016/j.cellsig.2021.110095
153
Lubna Siddiqui, Harshita Mishra, Pawan Kumar Mishra, Zeenat Iqbal, Sushama Talegaonkar. Novel 4-in-1 strategy to combat colon cancer, drug resistance and cancer relapse utilizing functionalized bioinspiring lignin nanoparticleMedical Hypotheses 2018; 121 doi: 10.1016/j.mehy.2018.09.003
154
Mark Primeaux, Xiangdong Liu, Saiprasad Gowrikumar, Iram Fatima, Kurt W. Fisher, Dhundy Bastola, Alex J. Vecchio, Amar B. Singh, Punita Dhawan. Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancerCancer Letters 2023; 579 doi: 10.1016/j.canlet.2023.216479
155
Iram Fatima, Rizwan Ahmad, Susmita Barman, Saiprasad Gowrikumar, Kristina Pravoverov, Mark Primeaux, Kurt W. Fisher, Amar B. Singh, Punita Dhawan. Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20British Journal of Cancer 2024; 130(6) doi: 10.1038/s41416-023-02570-x
156
Chih Kit Chung, Jomarien García-Couce, Yaima Campos, Dana Kralisch, Katja Bierau, Alan Chan, Ferry Ossendorp, Luis Javier Cruz. Doxorubicin Loaded Poloxamer Thermosensitive Hydrogels: Chemical, Pharmacological and Biological EvaluationMolecules 2020; 25(9) doi: 10.3390/molecules25092219
157
Yongxi Zhang, Huijie Jia, Zhiang Liu, Jing Guo, Yang Li, Ruipeng Li, Gaozan Zhu, Jie Li, Minjie Li, Xinyi Li, Shenggen Wang, Chengxue Dang, Tiesuo Zhao. D-MT prompts the anti-tumor effect of oxaliplatin by inhibiting IDO expression in a mouse model of colon cancerInternational Immunopharmacology 2021; 101 doi: 10.1016/j.intimp.2021.108203
158
Dennis Poel, Kirti K. Iyer, Bob van Gasteren, Beau B.C. Dagniaux, Erik van den Hombergh, Daniele V.F. Tauriello, Henk M.W. Verheul, Nielka P. van Erp. Elacridar improves sunitinib efficacy in colorectal cancer modelsEuropean Journal of Pharmaceutical Sciences 2025; 212 doi: 10.1016/j.ejps.2025.107194
159
Helena A. Herrmann, Mate Rusz, Dina Baier, Michael A. Jakupec, Bernhard K. Keppler, Walter Berger, Gunda Koellensperger, Jürgen Zanghellini. Thermodynamic Genome-Scale Metabolic Modeling of Metallodrug Resistance in Colorectal CancerCancers 2021; 13(16) doi: 10.3390/cancers13164130
160
Yiliu Chen, Shengsuo Ma, Dajin Pi, Yingchao Wu, Qian Zuo, Chongan Li, Mingzi Ouyang. Luteolin induces pyroptosis in HT-29 cells by activating the Caspase1/Gasdermin D signalling pathwayFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.952587
161
Tony R. Reid, Nacer Abrouk, Scott Caroen, Bryan Oronsky, Meaghan Stirn, Christopher Larson, Keola Beale, Susan J. Knox, George Fisher. ROCKET: Phase II Randomized, Active-controlled, Multicenter Trial to Assess the Safety and Efficacy of RRx-001 + Irinotecan vs. Single-agent Regorafenib in Third/Fourth Line Colorectal CancerClinical Colorectal Cancer 2023; 22(1) doi: 10.1016/j.clcc.2022.11.003
162
Wei-Liang Cui, Dong-Xiao Guo, Ning Wang, Zhi-Fan Wang, Jian-Bo Ji, Xiao Wang, Chun-Guo Yang, Yong-Qiang Lin, Shu-Qi Wang. Identification of chemosensitizing agents of colorectal cancer in Rauvolfia vomitoria using an NMR-based chemometric approachFrontiers in Chemistry 2023; 10 doi: 10.3389/fchem.2022.1069591
163
Jiehui Cai, Xinkang Zhang, Wanchun Xie, Zhiyang Li, Wei Liu, An Liu. Identification of a basement membrane-related gene signature for predicting prognosis and estimating the tumor immune microenvironment in breast cancerFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1065530
164
Mahdieh Farhoudi Sefidan Jadid, Elnaz Aghaei, Elham Taheri, Nasrin Seyyedsani, Reza Chavoshi, Samane Abbasi, Afshin Khorrami, Pouya Goleij, Saba Hajazimian, Sina Taefehshokr, Alireza Isazadeh, Dariush Shanehbandi. Melatonin increases the anticancer potential of doxorubicin in Caco‐2 colorectal cancer cellsEnvironmental Toxicology 2021; 36(6) doi: 10.1002/tox.23105
165
Farbod Bahreini, Nima Rezaei. Handbook of Cancer and Immunology2023;  doi: 10.1007/978-3-030-80962-1_336-1
166
Jin Young Min, Hye Min Kim, Geul Bang, Hae Won Jung, Yea Jin Kim, Sang-Yeop Lee, Dong Joon Kim, Sang Keun Ha, Truc Ngoc Kim Lam, Kwan Soo Hong, Hye Gwang Jeong, Jin Hee Kim, Eun Hee Han. Dual Roles of hABCB1 in Drug Resistance and Immune Evasion: Implications for Lung Cancer TherapyACS Omega 2026; 11(20) doi: 10.1021/acsomega.5c08960
167
Debasish Kumar Dey, Himanshi Gahlot, Sukkum Ngullie Chang, Sun Chul Kang. CopA3 treatment suppressed multidrug resistivity in HCT-116 cell line by p53-induced degradation of hypoxia-inducible factor 1αLife Sciences 2023; 329 doi: 10.1016/j.lfs.2023.121933
168
Bashdar Mahmud Hussen, Snur Rasool Abdullah, Abdulqahar Azizkhan Mohammed, Mohammed Fatih Rasul, Ali M. Hussein, Solat Eslami, Mark C. Glassy, Mohammad Taheri. Advanced strategies of targeting circular RNAs as therapeutic approaches in colorectal cancer drug resistancePathology - Research and Practice 2024; 260 doi: 10.1016/j.prp.2024.155402
169
Jakub Piekara, Dorota Piasecka-Kwiatkowska. Antioxidant Potential of Xanthohumol in Disease Prevention: Evidence from Human and Animal StudiesAntioxidants 2024; 13(12) doi: 10.3390/antiox13121559
170
Tao Liu, Rongmu Xia, Chenmeng Li, Xiaocong Chen, Xuemin Cai, Wengang Li. mRNA expression level of CDH2, LEP, POSTN, TIMP1 and VEGFC modulates 5‑fluorouracil resistance in colon cancer cellsExperimental and Therapeutic Medicine 2021; 22(3) doi: 10.3892/etm.2021.10455
171
Jennifer Haynes, Prasath Manogaran. Mechanisms and Strategies to Overcome Drug Resistance in Colorectal CancerInternational Journal of Molecular Sciences 2025; 26(5) doi: 10.3390/ijms26051988
172
Nina Hu, Ling Li, Jianqing Hao, Lifang Li, Mengmeng Pan, Jia He. FOXA2 enhances anoikis sensitivity in lung adenocarcinoma cells: Dual role of ABCA8 upregulation and NOX4 suppressionOncology Letters 2026; 32(3) doi: 10.3892/ol.2026.15777
173
Andrzej Kubiak, Matteo Chighizola, Carsten Schulte, Natalia Bryniarska, Julita Wesołowska, Maciej Pudełek, Małgorzata Lasota, Damian Ryszawy, Agnieszka Basta-Kaim, Piotr Laidler, Alessandro Podestà, Małgorzata Lekka. Stiffening of DU145 prostate cancer cells driven by actin filaments – microtubule crosstalk conferring resistance to microtubule-targeting drugsNanoscale 2021; 13(12) doi: 10.1039/D0NR06464E
174
Longsheng Xie, Christopher Lockhart, Dmitri K. Klimov, Mohsin Saleet Jafri. Combining Molecular Dynamics and Machine Learning to Predict Drug Resistance Causing Variants of BRAF in Colorectal CancerMolecules 2025; 30(17) doi: 10.3390/molecules30173556
175
Xingkang Wu, Yuemao Shen. PMN inhibits colorectal cancer cells through inducing mitotic arrest and p53-dependent apoptosis via the inhibition of tubulin polymerizationBiochemical and Biophysical Research Communications 2018; 499(4) doi: 10.1016/j.bbrc.2018.04.021
176
Veronika Skarkova, Vera Kralova, Barbora Vitovcova, Emil Rudolf. Selected Aspects of Chemoresistance Mechanisms in Colorectal Carcinoma—A Focus on Epithelial-to-Mesenchymal Transition, Autophagy, and ApoptosisCells 2019; 8(3) doi: 10.3390/cells8030234
177
Hao Lin, Liang Zhang, Caihua Zhang, Pengpeng Liu. Exosomal MiR‐500a‐3p promotes cisplatin resistance and stemness via negatively regulating FBXW7 in gastric cancerJournal of Cellular and Molecular Medicine 2020; 24(16) doi: 10.1111/jcmm.15524
178
Sonia Trombino, Simona Serini, Roberta Cassano, Gabriella Calviello. Xanthan gum-based materials for omega-3 PUFA delivery: Preparation, characterization and antineoplastic activity evaluationCarbohydrate Polymers 2019; 208 doi: 10.1016/j.carbpol.2019.01.001
179
N.A. Bhaskaran, L. Kumar. Treating colon cancers with a non-conventional yet strategic approach: An overview of various nanoparticulate systemsJournal of Controlled Release 2021; 336 doi: 10.1016/j.jconrel.2021.06.008
180
Patrycja Jaroniek, Marek Brzeziński, Magdalena Chmiela, Weronika Gonciarz. Doxorubicin loaded polylactide nanoparticles functionalized histamine promote apoptosis of human gastric cancer cells AGSScientific Reports 2025; 15(1) doi: 10.1038/s41598-025-99004-w
181
Daiki Kikuchi, Motonobu Saito, Katsuharu Saito, Yohei Watanabe, Yoshiko Matsumoto, Yasuyuki Kanke, Hisashi Onozawa, Suguru Hayase, Wataru Sakamoto, Teruhide Ishigame, Tomoyuki Momma, Shinji Ohki, Seiichi Takenoshita. Upregulated solute carrier family 37 member 1 in colorectal cancer is associated with poor patient outcome and metastasisOncology Letters 2017;  doi: 10.3892/ol.2017.7559
182
Haijun Wang, Jia Liu, Jinsong Li, Dan Zang, Xiaohui Wang, Yiyang Chen, Tengteng Gu, Wei Su, Na Song. Identification of gene modules and hub genes in colon adenocarcinoma associated with pathological stage based on WGCNA analysisCancer Genetics 2020; 242 doi: 10.1016/j.cancergen.2020.01.052
183
Vugar Yagublu, Bayram Bayramov, Christoph Reissfelder, Javahir Hajibabazade, Shalala Abdulrahimli, Michael Keese. Microarray-based detection and expression analysis of drug resistance in an animal model of peritoneal metastasis from colon cancerClinical & Experimental Metastasis 2024; 41(5) doi: 10.1007/s10585-024-10283-5
184
Ejlal Abu-El-Rub, Ayman Alzu’bi, Fatimah A. Almahasneh, Ramada R. Khaswaneh, Rawan Almazari, Amani Kasasbeh, Ala A. Aldamen, Heba F. AI-jariri, Amal Alomari, Tuqa Yousef, Raed M. Al-Zoubi. Inhibiting HSP90 changes the expression pattern of PINK1 and BNIP3 and induces oxidative stress in colon cancer cellsMolecular Biology Reports 2025; 52(1) doi: 10.1007/s11033-025-10303-x
185
Ye Song, Haoran Zhu, Junyang Wei, Shanxue Yin. Prognostic and therapeutic potential of disulfidptosis-related genes in colon adenocarcinoma: a comprehensive multi-omics studyCancer Cell International 2025; 25(1) doi: 10.1186/s12935-025-03855-2
186
Negar Moradian, Nima Rezaei. Handbook of Cancer and Immunology2023;  doi: 10.1007/978-3-030-80962-1_197-1
187
Chi Hin Cho, Tao Hu. Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies2020;  doi: 10.1016/B978-0-12-819937-4.09995-7
188
Junyi Ren, Bo Wang, Qifeng Wu, Guiling Wang. Combination of niclosamide and current therapies to overcome resistance for cancer: New frontiers for an old drugBiomedicine & Pharmacotherapy 2022; 155 doi: 10.1016/j.biopha.2022.113789
189
Bishu Zhang, Tuoya Qi, Jiewei Lin, Shuyu Zhai, Xuelong Wang, Leqi Zhou, Xiaxing Deng. KLF6-mediated recruitment of the p300 complex enhances H3K23su and cooperatively upregulates SEMA3C with FOSL2 to drive 5-FU resistance in colon cancer cellsExperimental & Molecular Medicine 2025; 57(3) doi: 10.1038/s12276-025-01424-1
190
Richard Jennemann, Martina Volz, Felix Bestvater, Claudia Schmidt, Karsten Richter, Sylvia Kaden, Johannes Müthing, Hermann-Josef Gröne, Roger Sandhoff. Blockade of Glycosphingolipid Synthesis Inhibits Cell Cycle and Spheroid Growth of Colon Cancer Cells In Vitro and Experimental Colon Cancer Incidence In VivoInternational Journal of Molecular Sciences 2021; 22(19) doi: 10.3390/ijms221910539
191
Quanzhong Su, Junying Song, Xiaoyi Zhang, Yuhuan Jiang, Hui Gao. Identification of AGT and CD44 in methotrexate-resistant colorectal cancer and reversal of methotrexate-resistancePathology - Research and Practice 2022; 229 doi: 10.1016/j.prp.2021.153717
192
Yangqian Shi, Chunliang Zhang, Wanyu Cao, Luyi Li, Kaili Liu, Hanyue Zhu, Fikadu Balcha, Yong Fang. Extracellular Vesicles from Lacticaseibacillus Paracasei PC-H1 Inhibit HIF-1α-Mediated Glycolysis of Colon Cancer Future Microbiology 2024; 19(3) doi: 10.2217/fmb-2023-0144
193
Zhenyu Xu, Hui Jiang, Yanhong Zhu, Huifang Wang, Jia Jiang, Lu Chen, Wenke Xu, Tao Hu, Chi Hin Cho. Cryptotanshinone induces ROS-dependent autophagy in multidrug-resistant colon cancer cellsChemico-Biological Interactions 2017; 273 doi: 10.1016/j.cbi.2017.06.003
194
Jin Liu, Tianle Liu, Chi Zhang, Ziyou Wang, Xinyi Zhang, Chuanchuan Hao, Dan Wang, Guohui Cheng. A mitochondrial-targeted nanomedicine based on hollow mesoporous silica nanoparticles for enhanced colorectal cancer therapyColloid and Interface Science Communications 2025; 66 doi: 10.1016/j.colcom.2025.100833
195
Seyed Hesamoddin Bidooki, Javier Quero, Javier Sánchez-Marco, Tania Herrero-Continente, Inés Marmol, Roberto Lasheras, Victor Sebastian, Manuel Arruebo, Jesús Osada, María Jesús Rodriguez-Yoldi. Squalene in Nanoparticles Improves Antiproliferative Effect on Human Colon Carcinoma Cells Through Apoptosis by Disturbances in Redox BalanceInternational Journal of Molecular Sciences 2024; 25(23) doi: 10.3390/ijms252313048
196
Wenli Liu, Yuqin Wang, Lijie Xia, Jinyao Li. Research Progress of Plant-Derived Natural Products against Drug-Resistant CancerNutrients 2024; 16(6) doi: 10.3390/nu16060797
197
Wei Zhang, Ying-Fang Fan, Chao-Yun Cai, Jing-Quan Wang, Qiu-Xu Teng, Zi-Ning Lei, Leli Zeng, Pranav Gupta, Zhe-Sheng Chen. Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer CellsFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01097
198
Haruko Takahashi, Iva Sovadinova, Kazuma Yasuhara, Satyavani Vemparala, Gregory A. Caputo, Kenichi Kuroda. Biomimetic antimicrobial polymers—Design, characterization, antimicrobial, and novel applicationsWIREs Nanomedicine and Nanobiotechnology 2023; 15(3) doi: 10.1002/wnan.1866
199
Aranka Brockmueller, Anjana Sajeev, Lenka Koklesova, Samson Mathews Samuel, Peter Kubatka, Dietrich Büsselberg, Ajaikumar B. Kunnumakkara, Mehdi Shakibaei. Resveratrol as sensitizer in colorectal cancer plasticityCancer and Metastasis Reviews 2024; 43(1) doi: 10.1007/s10555-023-10126-x
200
Domenico Ribatti, Roberto Tamma, Tiziana Annese. Epithelial-Mesenchymal Transition in Cancer: A Historical OverviewTranslational Oncology 2020; 13(6) doi: 10.1016/j.tranon.2020.100773
201
Kha Wai Hon, Rakesh Naidu. Synergistic Mechanisms of Selected Polyphenols in Overcoming Chemoresistance and Enhancing Chemosensitivity in Colorectal CancerAntioxidants 2024; 13(7) doi: 10.3390/antiox13070815
202
Yan‐Yan Chen, Shi‐Yuan Wen, Chun‐Miao Deng, Xing‐Feng Yin, Zheng‐Hua Sun, Miao‐Miao Jiang, Qing‐Yu He. Proteomic Analysis Reveals that Odoroside A Triggers G2/M Arrest and Apoptosis in Colorectal Carcinoma Through ROS‐p53 PathwayPROTEOMICS 2019; 19(15) doi: 10.1002/pmic.201900092
203
Ana García-Bautista, Aiora Cenigaonandia-Campillo, Anxo Rio-Vilariño, Lara Sanz-Criado, Marta Selva-Giménez, Raquel Perez-Antolín, Arancha Cebrián, Laura García-García, María Jesús Fernández-Aceñero, Natalia Baños-Herraiz, Lorena Mozas-Vivar, Estrella Núñez-Delicado, Jesús García-Foncillas, Óscar Aguilera. Metabolic regulation of histone acetylation by ACLY supports MDR1 expression in colorectal cancer and highlights a targetable vulnerabilityNeoplasia 2026; 77 doi: 10.1016/j.neo.2026.101314
204
Keren Zohar, Marco Strecker, Thomas Wartmann, Wenjie Shi, Frederike Stelter, Maximilian Doelling, Mihailo Andric, Or Kakhlon, Christian Täger, Denny Schanze, Michael Linnebacher, Michael Naumann, Daniel E. Stange, Dörthe Jechorek, Roland S. Croner, Michal Linial, Ulf D. Kahlert. Globo‐H diagnostic stratification and identification of DUSP14 as a candidate target in colorectal cancerInternational Journal of Cancer 2026; 159(4) doi: 10.1002/ijc.70461
205
Martina Čižmáriková, Viktória Háziková, Radka Michalková, Ondrej Franko, Beáta Lešková, Atila David Homolya, Juliana Gabzdilová, Peter Takáč. Targeting Multidrug Resistance in Cancer: Impact of Retinoids, Rexinoids, and Carotenoids on ABC TransportersInternational Journal of Molecular Sciences 2025; 26(22) doi: 10.3390/ijms262211157
206
Anna-Lena Scherr, Andreas Mock, Georg Gdynia, Nathalie Schmitt, Christoph E. Heilig, Felix Korell, Praveen Rhadakrishnan, Paula Hoffmeister, Klaus H. Metzeler, Klaus Schulze-Osthoff, Anna L. Illert, Melanie Boerries, Jörg Trojan, Oliver Waidmann, Johanna Falkenhorst, Jens Siveke, Philipp J. Jost, Michael Bitzer, Nisar P. Malek, Loredana Vecchione, Ivan Jelas, Benedikt Brors, Hanno Glimm, Albrecht Stenzinger, Svetlana P. Grekova, Tobias Gehrig, Henning Schulze-Bergkamen, Dirk Jäger, Peter Schirmacher, Mathias Heikenwalder, Benjamin Goeppert, Martin Schneider, Stefan Fröhling, Bruno C. Köhler. Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancerCell Death & Disease 2020; 11(10) doi: 10.1038/s41419-020-03092-7
207
Mehdi Rahmanian, Amir Seyfoori, Mohsen Ghasemi, Milad Shamsi, Ahmad Rezaei Kolahchi, Hassan Pezeshgi Modarres, Amir Sanati-Nezhad, Keivan Majidzadeh-A. In-vitro tumor microenvironment models containing physical and biological barriers for modelling multidrug resistance mechanisms and multidrug delivery strategiesJournal of Controlled Release 2021; 334 doi: 10.1016/j.jconrel.2021.04.024
208
Ana P. S. Koltun, José Trobia, Antonio M. Batista, Ervin K. Lenzi, Moises S. Santos, Fernando S. Borges, Kelly C. Iarosz, Iberê L. Caldas, Enrique C. Gabrick. Fractional Tumour-Immune Model with Drug ResistanceBrazilian Journal of Physics 2024; 54(2) doi: 10.1007/s13538-024-01417-x
209
Bushra Arif, Saba Yasir, Muhammad Saeed, M. Qaiser Fatmi. Natural products can be potential inhibitors of metalloproteinase II from Bacteroides fragilis to intervene colorectal cancerHeliyon 2024; 10(12) doi: 10.1016/j.heliyon.2024.e32838
210
María Belén Novoa Díaz, María Julia Martín, Claudia Gentili. Tumor microenvironment involvement in colorectal cancer progression <i>via</i> Wnt/β-catenin pathway: Providing understanding of the complex mechanisms of chemoresistanceWorld Journal of Gastroenterology 2022; 28(26): 3027-3046 doi: 10.3748/wjg.v28.i26.3027
211
Jongtae Roh, Inho Ahn, Jong-Ryoo Choi, Sung-Kyun Ko. 9-Deazaadenosine directly binds PYCR1 and inhibits cancer cell proliferation through disruption of NAD+ metabolismTranslational Oncology 2025; 60 doi: 10.1016/j.tranon.2025.102478
212
Sanaz Salek, Elham Moazamian, Afshin Mohammadi Bardbori, Seyedeh Azra Shamsdin. The anticancer effect of potential probiotic L. fermentum and L. plantarum in combination with 5-fluorouracil on colorectal cancer cellsWorld Journal of Microbiology and Biotechnology 2024; 40(5) doi: 10.1007/s11274-024-03929-9
213
Pedro Pedrosa, M. Luísa Corvo, Margarida Ferreira-Silva, Pedro Martins, Manuela Colla Carvalheiro, Pedro M. Costa, Carla Martins, L. M. D. R. S. Martins, Pedro V. Baptista, Alexandra R. Fernandes. Targeting Cancer Resistance via Multifunctional Gold NanoparticlesInternational Journal of Molecular Sciences 2019; 20(21) doi: 10.3390/ijms20215510
214
Soghra Bagheri, Ali A. Saboury. Hypothesis of using albumin to improve drug efficacy in cancers accompanied by hypoalbuminemiaXenobiotica 2021; 51(7) doi: 10.1080/00498254.2021.1929557
215
Prasath Manogaran, Aparna Anandan, Viswanadha Vijaya Padma. Isoliensinine augments the therapeutic potential of paclitaxel in multidrug‐resistant colon cancer stem cells and induced mitochondria‐mediated cell deathJournal of Biochemical and Molecular Toxicology 2023; 37(8) doi: 10.1002/jbt.23395
216
Sadra Samavarchi Tehrani, Fataneh Esmaeili, Moein Shirzad, Golnaz Goodarzi, Tooba Yousefi, Mahmood Maniati, Mortaza Taheri‐Anganeh, Amir Anushiravani. The critical role of circular RNAs in drug resistance in gastrointestinal cancersMedical Oncology 2023; 40(4) doi: 10.1007/s12032-023-01980-4
217
Xiaogang Shen, Xiaofei Zuo, Liang Liang, Lin Wang, Bin Luo. Integrating machine learning and single-cell trajectories to analyze T-cell exhaustion to predict prognosis and immunotherapy in colon cancer patientsFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1162843
218
Benny Mosoane, Georgios Lolas, Zodwa Dlamini. Colorectal Cancer Treatment Resistance2025;  doi: 10.1016/B978-0-443-33475-7.00014-7
219
Tapas Pradhan, Vikas Kumar, Evangeline Surya H, R. Krishna, Samu John, V. T. Jissa, S. Anjana, K. Chandramohan, S. Asha Nair. STIL Endows Oncogenic and Stem-Like Attributes to Colorectal Cancer Plausibly by Shh and Wnt SignalingFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.581671
220
Lijun Song, Jiabo Chen, Yuxuan Feng, Yujing Zhou, Feng Li, Guiqin Dai, Yue Yuan, Haosen Yi, Yupei Qian, Siyan Yang, Yang Chen, Wenchang Zhao. The Preparation of Gen-NH2-MCM-41@SA Nanoparticles and Their Anti-Rotavirus EffectsPharmaceutics 2022; 14(7) doi: 10.3390/pharmaceutics14071337
221
Kodappully S. Siveen, Afsheen Raza, Eiman I. Ahmed, Abdul Q. Khan, Kirti S. Prabhu, Shilpa Kuttikrishnan, Jericha M. Mateo, Hatem Zayed, Kakil Rasul, Fouad Azizi, Said Dermime, Martin Steinhoff, Shahab Uddin. The Role of Extracellular Vesicles as Modulators of the Tumor Microenvironment, Metastasis and Drug Resistance in Colorectal CancerCancers 2019; 11(6) doi: 10.3390/cancers11060746
222
Tatyana Grigoreva, Aleksandra Sagaidak, Angelina Romanova, Daria Novikova, Aleksander Garabadzhiu, Viacheslav Tribulovich. Establishment of drug-resistant cell lines under the treatment with chemicals acting through different mechanismsChemico-Biological Interactions 2021; 344 doi: 10.1016/j.cbi.2021.109510
223
Zhujun Xu. CRISPR/Cas9-mediated silencing of CD44: unveiling the role of hyaluronic acid-mediated interactions in cancer drug resistanceNaunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(5) doi: 10.1007/s00210-023-02840-8
224
Li-Min Mu, Rui-Jun Ju, Rui Liu, Ying-Zi Bu, Jing-Ying Zhang, Xue-Qi Li, Fan Zeng, Wan-Liang Lu. Dual-functional drug liposomes in treatment of resistant cancersAdvanced Drug Delivery Reviews 2017; 115 doi: 10.1016/j.addr.2017.04.006
225
Dilpreet Kaur Dhiman, Sankar Nath Sanyal, Vivek Vaish. Imatinib exhibit synergistic pleiotropy in the prevention of colorectal cancer by suppressing proinflammatory, cell survival and angiogenic signalingCellular Signalling 2020; 76 doi: 10.1016/j.cellsig.2020.109803
226
Aniruddha Murahar Kulkarni, Prasanna Kumar Reddy Gayam, Beena Thazhackavayal Baby, Jesil Mathew Aranjani. Epithelial-Mesenchymal Transition in Cancer: A Focus on Itraconazole, a Hedgehog InhibitorBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2025; 1880(2) doi: 10.1016/j.bbcan.2025.189279
227
Alice A. Ramos, Tânia Almeida, Bruna Lima, Eduardo Rocha. Cytotoxic activity of the seaweed compound fucosterol, alone and in combination with 5-fluorouracil, in colon cells using 2D and 3D culturingJournal of Toxicology and Environmental Health, Part A 2019; 82(9) doi: 10.1080/15287394.2019.1634378
228
Mingzhen Zhang, Chunhua Yang, Xiangji Yan, Junsik Sung, Pallavi Garg, Didier Merlin. Highly Biocompatible Functionalized Layer‐by‐Layer Ginger Lipid Nano Vectors Targeting P‐Selectin for Delivery of Doxorubicin to Treat Colon CancerAdvanced Therapeutics 2019; 2(12) doi: 10.1002/adtp.201900129
229
Blanca Cáceres, Alberto Ramirez, Esmeralda Carrillo, Gema Jimenez, Carmen Griñán-Lisón, Elena López-Ruiz, Yaiza Jiménez-Martínez, Juan A. Marchal, Houria Boulaiz. Deciphering the Mechanism of Action Involved in Enhanced Suicide Gene Colon Cancer Cell Killer Effect Mediated by Gef and ApoptinCancers 2019; 11(2) doi: 10.3390/cancers11020264
230
Yanfeng Liu, Lei Wu, Kai Li, Fengrui Liu, Li Wang, Dongling Zhang, Jing Zhou, Xuan Ma, Shengyu Wang, Shuanying Yang. Ornithine aminotransferase promoted the proliferation and metastasis of non‐small cell lung cancer via upregulation of miR‐21Journal of Cellular Physiology 2019; 234(8) doi: 10.1002/jcp.27939
231
Crescenzo Massaro, Elham Safadeh, Giulia Sgueglia, Hendrik G. Stunnenberg, Lucia Altucci, Carmela Dell’Aversana. MicroRNA-Assisted Hormone Cell Signaling in Colorectal Cancer ResistanceCells 2020; 10(1) doi: 10.3390/cells10010039
232
Jie Yin, Xiping Shen, Mei Li, Fangying Ni, Li Xu, Hua Lu. miR-329 regulates the sensitivity of 5-FU in chemotherapy of colorectal cancer by targeting E2F1Oncology Letters 2018;  doi: 10.3892/ol.2018.9121
233
Farida Elbassiouni, Wafaa El-Kholy, El-Sayed Elhabibi, Sarah Albogami, Eman Fayad. Comparative Study between Curcumin and Nanocurcumin Loaded PLGA on Colon Carcinogenesis Induced MiceNanomaterials 2022; 12(3) doi: 10.3390/nano12030324
234
Alejandro J. Español, Agustina Salem, María Di Bari, Ilaria Cristofaro, Yamila Sanchez, Ada M. Tata, María E. Sales, Irina V. Lebedeva. The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtypePLOS ONE 2020; 15(9) doi: 10.1371/journal.pone.0226450
235
Bi-Qing Cai, Wan-Meng Chen, Jia Zhao, Wei Hou, Jian-Cai Tang, Dali Zheng. Nrf3 Promotes 5-FU Resistance in Colorectal Cancer Cells via the NF-κB/BCL-2 Signaling Pathway In Vitro and In VivoJournal of Oncology 2021; 2021 doi: 10.1155/2021/9355555
236
Alice C. O’Farrell, Monika A. Jarzabek, Andreas U. Lindner, Steven Carberry, Emer Conroy, Ian S. Miller, Kate Connor, Liam Shiels, Eugenia R. Zanella, Federico Lucantoni, Adam Lafferty, Kieron White, Mariangela Meyer Villamandos, Patrick Dicker, William M. Gallagher, Simon A. Keek, Sebastian Sanduleanu, Philippe Lambin, Henry C. Woodruff, Andrea Bertotti, Livio Trusolino, Annette T. Byrne, Jochen H. M. Prehn. Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft ModelsCancers 2020; 12(10) doi: 10.3390/cancers12102978
237
Hafiz Zeshan Aqil, Yanhong Zhu, Masooma Hyder Khan, Yaqoot Khan, Beenish Sandhu, Muhammad Irfan, Hui Li. Zn–IMP 3D Coordination Polymers for Drug Delivery: Crystal Structure and Computational StudiesPolymers 2025; 18(1) doi: 10.3390/polym18010119
238
RamaRao Malla, Ganji Ganji. Citrus Flavones Luteolin and Apigenin Target Fundamental Mechanisms in Colon Cancer Onco Therapeutics 2022; 9(2) doi: 10.1615/OncoTherap.2022045072
239
Céline Hervieu, Niki Christou, Serge Battu, Muriel Mathonnet. The Role of Cancer Stem Cells in Colorectal Cancer: From the Basics to Novel Clinical TrialsCancers 2021; 13(5) doi: 10.3390/cancers13051092
240
Ke YAN, Ying WANG, Bao-Fei YAN, Yu-Lu MA, Yue-Dong YANG, Shi-Lin DAI, Fang FANG, Si-Cheng WU, Xiu-Xiu WANG, Heng-Bin WANG, Dan YANG, Liu-Qing DI, Hai-Bo CHENG, Jia LIU, Sheng-Jin LIU. Establishment of X-ray diffraction fingerprints for identification of different configuration Realgar and its antitumor activityChinese Journal of Analytical Chemistry 2023; 51(5) doi: 10.1016/j.cjac.2022.100212
241
Yu Gan, Hao Yang, Maijian Wang, Jida Li. Advances in drug resistance and resistance mechanisms of four colorectal cancer-associated gut microbiotaPeerJ 2025; 13 doi: 10.7717/peerj.19535
242
Mathias Dahlmann, Rebecca Werner, Benedikt Kortüm, Dennis Kobelt, Wolfgang Walther, Ulrike Stein. Restoring Treatment Response in Colorectal Cancer Cells by Targeting MACC1-Dependent ABCB1 Expression in Combination TherapyFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00599
243
Habiba Tariq, Zobia Noreen, Aftab Ahmad, Laraib Khan, Mashhood Ali, Muhammad Malik, Aneela Javed, Faisal Rasheed, Alina Fatima, Tanil Kocagoz, Ugur Sezerman, Habib Bokhari, Grzegorz Woźniakowski. Colibactin possessing E. coli isolates in association with colorectal cancer and their genetic diversity among Pakistani populationPLOS ONE 2022; 17(11) doi: 10.1371/journal.pone.0262662
244
Cornelia Amalinei, Diana-Lavinia Pricope, Adriana Grigoras¸. Cancer Stem Cells and Signaling Pathways2024;  doi: 10.1016/B978-0-443-13212-4.00018-0
245
Chung-Yen Huang, Ching-Ying Huang, Yu-Chen Pai, Been-Ren Lin, Tsung-Chun Lee, Pi-Hui Liang, Linda Chia-Hui Yu. Glucose Metabolites Exert Opposing Roles in Tumor ChemoresistanceFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01282
246
Gabriel Cutshaw, Nora Hassan, Saji Uthaman, Xiaona Wen, Bhuminder Singh, Anwesha Sarkar, Rizia Bardhan. Monitoring Metabolic Changes in Response to Chemotherapies in Cancer with Raman Spectroscopy and MetabolomicsAnalytical Chemistry 2023; 95(35) doi: 10.1021/acs.analchem.3c02073
247
Yu Han, Yaping Chen, Xingchun Xiao, Zhong Li, Wentai Shi, Qiling Lin. Exploring the mechanism of Grifolin in inhibiting the malignant progression of colon cancer cells mediated by the PDGFRB/PI3K/AKT signaling pathway based on bioinformatics analysis and network pharmacologyLetters in Drug Design & Discovery 2025; 22(2) doi: 10.1016/j.lddd.2025.100018
248
Yong-Qiang Hou, Ying-Ying Wang, Xing-Can Wang, Yao Liu, Chun-Ze Zhang, Zhe-Sheng Chen, Zhe Zhang, Wei Wang, De-Xin Kong. Multifaceted anti-colorectal tumor effect of digoxin on HCT8 and SW620 cells in vitro Gastroenterology Report 2020; 8(6) doi: 10.1093/gastro/goaa076
249
Entaz Bahar, Ji-Ye Kim, Hyonok Yoon. Chemotherapy Resistance Explained through Endoplasmic Reticulum Stress-Dependent SignalingCancers 2019; 11(3) doi: 10.3390/cancers11030338
250
Ping Qiu, Jingqun Liu, Lisha Zhao, Pinghu Zhang, Weike Wang, Dan Shou, Jinjun Ji, Changyu Li, Kequn Chai, Yu Dong. Inoscavin A, a pyrone compound isolated from a Sanghuangporus vaninii extract, inhibits colon cancer cell growth and induces cell apoptosis via the hedgehog signaling pathwayPhytomedicine 2022; 96 doi: 10.1016/j.phymed.2021.153852
251
Wen-Shih Huang, Kuen-Lin Wu, Cheng-Nan Chen, Shun-Fu Chang, Ding-Yu Lee, Ko-Chao Lee. Amphiregulin Upregulation in Visfatin-Stimulated Colorectal Cancer Cells Reduces Sensitivity to 5-Fluororacil CytotoxicityBiology 2024; 13(10) doi: 10.3390/biology13100821
252
Chengyuan Xu, Tengfei Li, Lin Zhang, Qin Zhang, Shanshan Cai, Qiangqiang Fu, Siqi Zhang. LOXL2⁺ cancer-associated fibroblasts shape WNT signaling to drive chemoresistance and poor outcomes in colorectal cancer: Insights from multi-omics and epidemiological analysesNeoplasia 2026; 72 doi: 10.1016/j.neo.2025.101267
253
Amirsaeed Sabeti Aghabozorgi, Mostafa Moradi Sarabi, Reza Jafarzadeh-Esfehani, Shabnaz Koochakkhani, Marziyeh Hassanzadeh, Soudabeh Kavousipour, Ebrahim Eftekhar. Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acidsWorld Journal of Gastrointestinal Oncology 2020; 12(9): 942-956 doi: 10.4251/wjgo.v12.i9.942
254
Xinyu Wang, Jinbao Xiao, Yongping Yang, Tao Li. Nanomedicine-Based Therapeutic Approaches in Colorectal Cancer Using Patient-Derived Xenograft Models: Prospects and ChallengesInternational Journal of Nanomedicine 2026;  doi: 10.2147/IJN.S573763
255
Yi-Min Shao, Yong Wu. Inhibitory effects of piperine on proliferation, migration, and invasion of human colon cancer SW480 cellsWorld Chinese Journal of Digestology 2021; 29(12) doi: 10.11569/wcjd.v29.i12.639
256
Wenqian Bai, Haiying Chen, Junyao Li, Wenrong Cai, Yong Kong, Xiaoming Zuo. Calcium carbonate hollow microspheres encapsulated cellulose nanofiber/sodium alginate hydrogels as a sequential delivery systemInternational Journal of Biological Macromolecules 2025; 309 doi: 10.1016/j.ijbiomac.2025.142839
257
Elena Kazakova, Militsa Rakina, Tatiana Sudarskikh, Pavel Iamshchikov, Anna Tarasova, Liubov Tashireva, Sergei Afanasiev, Alexei Dobrodeev, Lilia Zhuikova, Nadezhda Cherdyntseva, Julia Kzhyshkowska, Irina Larionova. Angiogenesis regulators S100A4, SPARC and SPP1 correlate with macrophage infiltration and are prognostic biomarkers in colon and rectal cancersFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1058337
258
Vineela Parvathaneni, Rasha S. Elbatanony, Snehal K. Shukla, Nishant S. Kulkarni, Dipti D. Kanabar, Gautam Chauhan, Seyoum Ayehunie, Zhe-Sheng Chen, Aaron Muth, Vivek Gupta. Bypassing P-glycoprotein mediated efflux of afatinib by cyclodextrin complexation – Evaluation of intestinal absorption and anti-cancer activityJournal of Molecular Liquids 2021; 327 doi: 10.1016/j.molliq.2020.114866
259
H. Deshmukh, S. Samanta, J.R. Kanwar, M. Verma, R. Chowdhary, P. Kar. Conformational landscapes and binding free energies of multitarget phytochemicals reveal molecular recognition mechanisms in colorectal cancer-associated proteinsSAR and QSAR in Environmental Research 2026; 37(6) doi: 10.1080/1062936X.2026.2685532
260
Liangpan Shi, Yibin Su, Zhihua Zheng, Jinyu Qi, Weidong Wang, Cunchuan Wang. miR‑146b‑5p promotes colorectal cancer progression by targeting TRAF6Experimental and Therapeutic Medicine 2022; 23(3) doi: 10.3892/etm.2022.11155
261
Shujie Liu, Xiaonan Sima, Xingzhu Liu, Hongping Chen. Zinc Finger Proteins: Functions and Mechanisms in Colon CancerCancers 2022; 14(21) doi: 10.3390/cancers14215242
262
Qianshi Zhang, Zhen Feng, Yongnian Zhang, Shasha Shi, Yu Zhang, Shuangyi Ren, Toshimi Chiba. Identification and Verification of a 17 Immune‐Related Gene Pair Prognostic Signature for Colon CancerBioMed Research International 2021; 2021(1) doi: 10.1155/2021/6057948
263
Mohd Akil, Chandra Shekhar Yadav, Abdul Rahman Khan, Naseem Ahmad, Iqbal Azad. Exploring Pyrazole Derivatives as Potential Anticancer Agents: A ReviewChemistrySelect 2026; 11(11) doi: 10.1002/slct.202504987
264
Xue-jia Kang, Hui-yuan Wang, Hui-ge Peng, Bin-fan Chen, Wen-yuan Zhang, Ai-hua Wu, Qin Xu, Yong-zhuo Huang. Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapyActa Pharmacologica Sinica 2017; 38(6) doi: 10.1038/aps.2017.10
265
Farah Hudaib, Sanaa Bardaweel, Wesam Darwish, Salah Abdelrazig, Lina A. Dahabiyeh. LC-MS-based metabolomics revealed promising role of leukotriene receptor antagonists against colorectal cancerJournal of Chromatography B 2025; 1267 doi: 10.1016/j.jchromb.2025.124824
266
Sara Jaramillo‐Carmona, Rafael Guillén‐Bejarano, Ana Jiménez‐Araujo, Rocío Rodríguez‐Arcos, Sergio López. In Vitro Toxicity of Asparagus Saponins in Distinct Multidrug‐Resistant Colon Cancer CellsChemistry & Biodiversity 2018; 15(11) doi: 10.1002/cbdv.201800282
267
Rongrong Fu, Rui Chang, Andong Peng, Changshun Feng, Weifan Zhu, Yi Chen, Xue Tian, Rui Wang, Hui Yan, Dianlong Jia, Jun Li. Efficient treatment of colon cancer with codelivery of TRAIL and imatinib by liposomesPharmaceutical Development and Technology 2024; 29(1) doi: 10.1080/10837450.2024.2301763
268
Jinbao Chen, Chenqi Wu, Kun Yu, Jinpei Liu, Jiahua Yang, Wei Li, Xiaoxia Tang, Yihai Shi, Ke Xu, Yi Chen, Xiaoyu Qin. Bufalin targets the SRC-3/c-Myc pathway in chemoresistant cells to regulate metastasis induced by chemoresistance in colorectal cancerJournal of Cancer Research and Clinical Oncology 2025; 151(2) doi: 10.1007/s00432-025-06124-x
269
Joyeeta T. Khan, Saloni Sood, Veronica Piedra, Emel Seker, Harish Rajak, Chandrabose Karthikeyan, Charles R. Ashby, Rupak Pathak, Amit K. Tiwari. The hidden hand of endoplasmic reticulum stress in anticancer drug resistanceCritical Reviews in Oncology/Hematology 2026; 217 doi: 10.1016/j.critrevonc.2025.104998
270
Isaac Micallef, Byron Baron. The Mechanistic Roles of ncRNAs in Promoting and Supporting Chemoresistance of Colorectal CancerNon-Coding RNA 2021; 7(2) doi: 10.3390/ncrna7020024
271
Chengyuan Zhang, Xuemei Zhou, Hanyi Zhang, Xuanliang Han, Baijun Li, Ran Yang, Xing Zhou. Recent Progress of Novel Nanotechnology Challenging the Multidrug Resistance of CancerFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.776895
272
Veronique Mathieu, Breana Laguera, Marco Masi, Sara Adriana Dulanto, Tanner W. Bingham, Lucas W. Hernandez, David Sarlah, Antonio Evidente, Denis L. J. Lafontaine, Alexander Kornienko, Michelle A. Lane. Amaryllidaceae Alkaloids Decrease the Proliferation, Invasion, and Secretion of Clinically Relevant Cytokines by Cultured Human Colon Cancer CellsBiomolecules 2022; 12(9) doi: 10.3390/biom12091267
273
Leila Dadgar-Zankbar, Zahra Elahi, Aref Shariati, Azad Khaledi, Shabnam Razavi, Amin Khoshbayan. Exploring the role of Fusobacterium nucleatum in colorectal cancer: implications for tumor proliferation and chemoresistanceCell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-024-01909-y
274
Hiromi Kurokawa, Hirofumi Matsui. The Cytotoxicity of Doxorubicin Can Be Accelerated by a Combination of Hyperthermia and 5-Aminolevulinic AcidAntioxidants 2021; 10(10) doi: 10.3390/antiox10101531
275
Jianqiao Yang, Chen Li, Zhu Wang, Kewei Jiang. Multi-omics analysis of the biological function of the VEGF family in colon adenocarcinomaFunctional & Integrative Genomics 2024; 24(6) doi: 10.1007/s10142-024-01493-x
276
Santosh Kumar, Valid Gahramanov, Shivani Patel, Julia Yaglom, Lukasz Kaczmarczyk, Ivan A. Alexandrov, Gabi Gerlitz, Mali Salmon-Divon, Michael Y. Sherman. Evolution of Resistance to Irinotecan in Cancer Cells Involves Generation of Topoisomerase-Guided Mutations in Non-Coding Genome That Reduce the Chances of DNA BreaksInternational Journal of Molecular Sciences 2023; 24(10) doi: 10.3390/ijms24108717
277
Munmun Panda, Stuti Biswal, Bijesh K. Biswal. Evodiamine potentiates cisplatin-induced cell death and overcomes cisplatin resistance in non-small-cell lung cancer by targeting SOX9-β‐catenin axisMolecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09477-7
278
Qing Zhang, Haixu Zhang, Jiage Ding, Hongyan Liu, Huizhong Li, Hailong Li, Mengmeng Lu, Yangna Miao, Liantao Li, Junnian Zheng. Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer ModelsJournal of Immunology Research 2018; 2018 doi: 10.1155/2018/4263520
279
Shunjin Li, Yue Ren, Xuhang Lu, Yuequan Shen, Xue Yang. Cryo-EM structure of human ABCB8 transporter in nucleotide binding stateBiochemical and Biophysical Research Communications 2021; 557 doi: 10.1016/j.bbrc.2021.04.007
280
Henis Patel, Siddhant Palekar, Akanksha Patel, Ketan Patel. Ibrutinib amorphous solid dispersions with enhanced dissolution at colonic pH for the localized treatment of colorectal cancerInternational Journal of Pharmaceutics 2023; 641 doi: 10.1016/j.ijpharm.2023.123056
281
Jingqi Shi, Dongbo Jiang, Shuya Yang, Yuanjie Sun, Jing Wang, Xiyang Zhang, Yang Liu, Yuchen Lu, Kun Yang. Molecular profile reveals immune-associated markers of lymphatic invasion in human colon adenocarcinomaInternational Immunopharmacology 2020; 83 doi: 10.1016/j.intimp.2020.106402
282
PULI SAGAR, RAMASAMY RAVEENDRAN. CLEISTANTHIN B SHOWS A POTENT CYTOTOXIC ACTIVITY AGAINST COLORECTAL CANCER CELLSAsian Journal of Pharmaceutical and Clinical Research 2022;  doi: 10.22159/ajpcr.2022.v15i3.43953
283
Bouchra Ghazi, Adil El Ghanmi, Sarah Kandoussi, Amina Ghouzlani, Abdallah Badou. CAR T-cells for colorectal cancer immunotherapy: Ready to go?Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.978195
284
Mehri Joghataei, Fakhri Shahidi, Gholamreza Pouladfar, Seyed Ali Mortazavi, Abbas Ghaderi. Probiotic potential comparison of Lactobacillus strains isolated from Iranian traditional food products and human feces with standard probiotic strainsJournal of the Science of Food and Agriculture 2019; 99(15) doi: 10.1002/jsfa.9945
285
Dharambir Kashyap, Riya Sharma, Vimal Singh Munda, Vivek Kumar Garg, Sheetal Thakur, Deepti Sharma, Charles Odilichukwu R. Okpala, Vandana Dhiman. Flavonoids Against Cancer Hallmarks2026;  doi: 10.1016/B978-0-443-42855-5.00010-8
286
Srijeyagowri Murugaiyaa Pandiyan, Priyadharshini Shanmugaraj, Jeevitha Priya Manoharan, Subramanian Vidyalakshmi. A network pharmacological approach to reveal the multidrug resistance reversal and associated mechanisms of acetogenins against colorectal cancerJournal of Biomolecular Structure and Dynamics 2022; 40(24) doi: 10.1080/07391102.2021.1990130
287
Elham Khalili, Ali Afgar, Azam Rajabpour, Seyed Hamid Aghaee-Bakhtiari, Khadijeh Jamialahmadi, Ladan Teimoori-Toolabi. MiR-548c-3p through suppressing Tyms and Abcg2 increases the sensitivity of colorectal cancer cells to 5-fluorouracilHeliyon 2023; 9(11) doi: 10.1016/j.heliyon.2023.e21775
288
Manali Rupareliya, Jyotsna Vitore, Ajinkya Aher, Mansi Patil, Melroy D'Sa, Dhanashree Guram, Yash Jadhav, Prabhanjan Giram. Nano Drug Delivery Systems for Colon Cancer2026;  doi: 10.1016/B978-0-443-40443-6.00019-2
289
Jinxing Huang, Cheng Zhuang, Jie Chen, Xuanming Chen, Xiaojie Li, Ting Zhang, Bing Wang, Qiyi Feng, Xiuli Zheng, Meng Gong, Qiyong Gong, Kai Xiao, Kui Luo, Weimin Li. Targeted Drug/Gene/Photodynamic Therapy via a Stimuli‐Responsive Dendritic‐Polymer‐Based Nanococktail for Treatment of EGFR‐TKI‐Resistant Non‐Small‐Cell Lung CancerAdvanced Materials 2022; 34(27) doi: 10.1002/adma.202201516
290
Xiaohan Shen, Jinming Han. Overexpression of gene DEP domain containing 1 and its clinical prognostic significance in colorectal cancerJournal of Clinical Laboratory Analysis 2020; 34(12) doi: 10.1002/jcla.23634
291
Meghana Patel, Manish Nandpal, Nikunj Parekh, Samir Gunvantbhai Patel, Alkeshkumar Patel. Biosimilars for Cancer Treatment2024;  doi: 10.1007/978-981-97-3001-8_4
292
Cihan Suleyman Erdogan, Yasmine Al Hassadi, Basak Aru, Bayram Yılmaz, Burcu Gemici. Combinatorial effects of melatonin and paclitaxel differ depending on the treatment scheme in colorectal cancer in vitroLife Sciences 2022; 308 doi: 10.1016/j.lfs.2022.120927
293
Yi-Fang Ho, Ya-Hsuan Tsai, Ting-Yan Jian, Han-Huei Lin, Lie-Fen Shyur, Meng-Ting Chang, Alexander Lin, You-Zhong Zhan, Yu-Ling Lin. Phytogalactolipids triggered oxidative stress to inhibit drug-resistant colorectal cancer by suppressing interferon-α-induced protein 6Phytomedicine 2026; 153 doi: 10.1016/j.phymed.2026.157960
294
Eric Chekwube Aniogo, Blassan Plackal Adimuriyil George, Heidi Abrahamse. The role of photodynamic therapy on multidrug resistant breast cancerCancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0815-0
295
Yuedi Ding, Jun Fan, Zhenqiang Fan, Kai Zhang. γ-Tocotrienol reverses multidrug resistance of breast cancer cells through the regulation of the γ-Tocotrienol-NF-κB-P-gp axisThe Journal of Steroid Biochemistry and Molecular Biology 2021; 209 doi: 10.1016/j.jsbmb.2021.105835
296
Chih‐Yuan Huang, Ju‐Huei Chien, Kai‐Fu Chang, Chih‐Yen Hsiao, Ya‐Chih Huang, Yi‐Ting Chen, Ming‐Yi Hsu, Ming‐Chang Hsieh, Nu‐Man Tsai. Cedrus atlantica extract exerts antiproliferative effect on colorectal cancer through the induction of cell cycle arrest and apoptosisFood Science & Nutrition 2022; 10(5) doi: 10.1002/fsn3.2786
297
Jing-Yu Feng, Wang-Wei Zhang, Xiu-Xiu Zhang, Qian Zhong, Kiran Thakur, Zhao-Jun Wei. Liriope muscari baily saponin C induces apoptosis and autophagy in HCT116 cells via ROS generationFood Bioscience 2025; 65 doi: 10.1016/j.fbio.2025.106073
298
Irina Nakashidze, Nina Petrović, Nino Kedelidze, Begum Dariya. Colon Cancer Diagnosis and Therapy Vol. 32022;  doi: 10.1007/978-3-030-72702-4_4
299
Sisi Li, Jiajie Jing, Yueming Chen, Enjie Chi, Bingyan Wang, Ziwen Xie, Wenya Yang, Hongqiang Shen, Jianping Pan. Precision sniper for solid tumors: CAR-NK cell therapyCancer Immunology, Immunotherapy 2025; 74(9) doi: 10.1007/s00262-025-04106-z
300
Faezeh Mahdavi, Arezo Rahiminezhad, Aref Jafarpoor Kami, Amir Arasteh, Mehdi Ebrahimi. Preparation of New Liposomal Daunorubicin and Evaluation of its Anti-colorectal Cancer Effect in HCT116 CellsCurrent Bioactive Compounds 2025; 21(8) doi: 10.2174/0115734072312484241010124144
301
Sebastian Steigert, Joachim Brouwers, Tim Vanuytsel, Sara Verbandt, Sabine Tejpar, Stefan Oswald, Patrick Augustijns. Protein abundance of drug transporters and drug-metabolizing enzymes in paired healthy and tumor tissue from colorectal cancer patientsInternational Journal of Pharmaceutics 2025; 671 doi: 10.1016/j.ijpharm.2025.125216
302
Chengqiong Mao, Yan Zhao, Fang Li, Zibo Li, Shaomin Tian, Waldemar Debinski, Xin Ming. P-glycoprotein targeted and near-infrared light-guided depletion of chemoresistant tumorsJournal of Controlled Release 2018; 286 doi: 10.1016/j.jconrel.2018.08.005
303
Nanasaheb D. Thorat, Joanna Bauer, Syed A.M. Tofail, Victoria Gascón Pérez, Raghvendra A. Bohara, Hemraj M. Yadav. Silica nano supra-assembly for the targeted delivery of therapeutic cargo to overcome chemoresistance in cancerColloids and Surfaces B: Biointerfaces 2020; 185 doi: 10.1016/j.colsurfb.2019.110571
304
Min Xia, Xuyu Zu, Zuyao Chen, Gebo Wen, Jing Zhong. Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistanceCancer Letters 2021; 523 doi: 10.1016/j.canlet.2021.09.038
305
Amirsaeed Sabeti Aghabozorgi, Samaneh Sharif, Reza Jafarzadeh-Esfehani, Saba Vakili, Mohammad Reza Abbaszadegan. Role of miRNA Gene Variants in the Susceptibility and Pharmacogenetics of Colorectal CancerPharmacogenomics 2021; 22(5) doi: 10.2217/pgs-2020-0159
306
Eleonora Martinis, Silvia Tonon, Viviana Valeri, Alessandra Colamatteo, Carolina Ricci, Caterina Trevisan, Eleonora Capezzali, Matteo Pivetta, Serena Battista, Marta Mozzon, Alessandro Uzzau, Giuseppe Matarese, Andrea Cossarizza, Barbara Frossi, Carlo Pucillo. Immunophenotypic skewing of B cells toward IgD⁻CD27⁻IgG⁺ subtype and metabolic attenuation in colorectal cancerScientific Reports 2026; 16(1) doi: 10.1038/s41598-026-41446-x
307
Qiang Gao, Xiu-xiu Li, Yi-ming Xu, Jin-zhao Zhang, Shi-di Rong, Yan-qing Qin, Jing Fang. IRE1α-targeting downregulates ABC transporters and overcomes drug resistance of colon cancer cellsCancer Letters 2020; 476 doi: 10.1016/j.canlet.2020.02.007
308
Tadanobu Shimura, Chengzeng Yin, Ruiya Ma, Aiying Zhang, Yuka Nagai, Aoi Shiratori, Hana Ozaki, Shinji Yamashita, Koki Higashi, Yuki Sato, Hiroki Imaoka, Takahito Kitajima, Mikio Kawamura, Yuhki Koike, Yoshiki Okita, Shigeyuki Yoshiyama, Masaki Ohi, Akinobu Hayashi, Hiroshi Imai, Xueming Zhang, Yoshinaga Okugawa, Yuji Toiyama. The prognostic importance of the negative regulators of ferroptosis, GPX4 and HSPB1, in patients with colorectal cancerOncology Letters 2025; 29(3) doi: 10.3892/ol.2025.14890
309
Yi-Siou Chiou, Yu-Nu Zheng, Mei-Ling Tsai, Ching-Shu Lai, Chi-Tang Ho, Min-Hsiung Pan. 5-Demethylnobiletin more potently inhibits colon cancer cell growth than nobiletin in vitro and in vivo Journal of Food Bioactives 2018;  doi: 10.31665/JFB.2018.2143
310
Lixue Wang, Jinlong Chen, Qijun Chen, Hui Song, Ziqian Wang, Wen Xing, Siyao Jin, Xueying Song, Hua Yang, Wenhua Zhao, Kai Wang. The Gut Microbiota Metabolite Urolithin B Prevents Colorectal Carcinogenesis by Remodeling Microbiota and PD-L1/HLA-BOxidative Medicine and Cellular Longevity 2023; 2023 doi: 10.1155/2023/6480848
311
Changcheng Wang, Jia Guo, Zengan Wu. lncRNA PTCSC1 Promotes TRAIL Resistance through FOXO3a Pathway in HCT116 and SW480 Cells Journal of Environmental Pathology, Toxicology and Oncology 2025; 44(2) doi: 10.1615/JEnvironPatholToxicolOncol.2024053010
312
YUQIN YIN, YU WU, HONGLIANG HUANG, YINGYING DUAN, ZHONGWEN YUAN, LIHUI CAO, JINJIN YING, YONGHENG ZHOU, SENLING FENG. The superiority of PMFs on reversing drug resistance of colon cancer and the effect on aerobic glycolysis-ROS-autophagy signaling axisOncology Research 2024; 32(12) doi: 10.32604/or.2024.048778
313
Nasim Sepay, Tae Wan Kim, Tejinder Singh, Mohuya Paul, Hye Jeong Kong, Jae Sung Ryu, Nandan Ghosh, Seob Jeon, Soohyeon Lee, Tae Sung Ahn, Moo-Jun Baek, Dong Hyun Kang, Jungkyun Im. Targeted delivery of oxaliplatin to colorectal cancer using the cancer-specific cell-penetrating peptide BR2Journal of Drug Delivery Science and Technology 2024; 101 doi: 10.1016/j.jddst.2024.106261
314
Wen‐Shih Huang, Chien‐Tsong Lin, Cheng‐Nan Chen, Shun‐Fu Chang, Hsin‐I Chang, Ko‐Chao Lee. Metformin increases the cytotoxicity of oxaliplatin in human DLD‐1 colorectal cancer cells through down‐regulating HMGB1 expressionJournal of Cellular Biochemistry 2018; 119(8) doi: 10.1002/jcb.26898
315
Agnese Po, Anna Citarella, Giuseppina Catanzaro, Zein Mersini Besharat, Sofia Trocchianesi, Francesca Gianno, Claudia Sabato, Marta Moretti, Enrico De Smaele, Alessandra Vacca, Micol Eleonora Fiori, Elisabetta Ferretti. Hedgehog-GLI signalling promotes chemoresistance through the regulation of ABC transporters in colorectal cancer cellsScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-70871-9
316
Himangshu Sonowal, Pabitra B. Pal, Jian-Jun Wen, Sanjay Awasthi, Kota V. Ramana, Satish K. Srivastava. Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiotoxicityScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-03284-w
317
Keefe Guang Zhi Lee, Maria V. Babak, Andrea Weiss, Paul J. Dyson, Patrycja Nowak‐Sliwinska, Diego Montagner, Wee Han Ang. Development of an Efficient Dual‐Action GST‐Inhibiting Anticancer Platinum(IV) ProdrugChemMedChem 2018; 13(12) doi: 10.1002/cmdc.201800105
318
Ting Liu, Jing Zhang, Kangdi Li, Lingnan Deng, Hongxiang Wang. Combination of an Autophagy Inducer and an Autophagy Inhibitor: A Smarter Strategy Emerging in Cancer TherapyFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00408
319
Xiao‑Li Zheng, Hong‑Gang Yu. Wnt6 contributes tumorigenesis and development of colon cancer via its effects on cell proliferation, apoptosis, cell‑cycle and migrationOncology Letters 2018;  doi: 10.3892/ol.2018.8729
320
Songtao Li, Man Ding, Mangmang Feng, Xiaxia Fan, Zhuoyu Li. Polyunsaturated Fatty Acids in Quinoa Induce Ferroptosis of Colon Cancer by Suppressing StemnessJournal of Agricultural and Food Chemistry 2024; 72(29) doi: 10.1021/acs.jafc.4c00118
321
Francis Yew Fu Tieng, Rashidah Baharudin, Nadiah Abu, Ryia-Illani Mohd Yunos, Learn-Han Lee, Nurul-Syakima Ab Mutalib. Single Cell Transcriptome in Colorectal Cancer—Current Updates on Its Application in Metastasis, Chemoresistance and the Roles of Circulating Tumor CellsFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00135
322
Zhendong Liu, Yuyang Xu, Xin Liu, Baochun Wang. PCDH7 knockdown potentiates colon cancer cells to chemotherapy via inducing ferroptosis and changes in autophagy through restraining MEK1/2/ERK/c-Fos axisBiochemistry and Cell Biology 2022; 100(6) doi: 10.1139/bcb-2021-0513
323
Na An, Ying Sun, Ligang Ma, Shengli Shi, Xiaoke Zheng, Weisheng Feng, Zhiming Shan, Yongguang Han, Le Zhao, Huiming Wu. Helveticoside Exhibited p53-dependent Anticancer Activity Against Colorectal CancerArchives of Medical Research 2020; 51(3) doi: 10.1016/j.arcmed.2020.02.007
324
Hande Beklen, Gizem Gulfidan, Kazim Yalcin Arga, Adil Mardinoglu, Beste Turanli. Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal CancerFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01273
325
Mostafa Mostafazadeh, Houman Kahroba, Sanya Haiaty, Abbas P. TazeKand, Nasser Samadi, Reza Rahbarghazi, Mohammad Nouri. In vitro exosomal transfer of Nrf2 led to the oxaliplatin resistance in human colorectal cancer LS174T cellsCell Biochemistry and Function 2022; 40(4) doi: 10.1002/cbf.3703
326
Nina Rembiałkowska, Vitalij Novickij, Dagmara Baczyńska, Magda Dubińska-Magiera, Jolanta Saczko, Julia Rudno-Rudzińska, Magdalena Maciejewska, Julita Kulbacka. Micro- and Nanosecond Pulses Used in Doxorubicin Electrochemotherapy in Human Breast and Colon Cancer Cells with Drug ResistanceMolecules 2022; 27(7) doi: 10.3390/molecules27072052
327
Tariq Ahmad Mir, S. Wazed Ali, Showkat Ali Ganie. Polysaccharide Biomaterials in Cancer Research and Therapy2026;  doi: 10.1002/9781394345472.ch3
328
Harmeet Kaur, Jasbir Singh, Balasubramanian Narasimhan. Synthesis and evaluation of novel naphthol diazenyl scaffold based Schiff bases as potential antimicrobial and cytotoxic agents against human colorectal carcinoma cell line (HT-29)BMC Chemistry 2019; 13(1) doi: 10.1186/s13065-019-0558-y
329
Farbod Bahreini, Nima Rezaei. Cancer ChallengesHandbook of Cancer and Immunology 2025; 10 doi: 10.1007/978-3-032-00775-9_336
330
Veronika Skarkova, Adam Skarka, Monika Manethova, Afroditi A Stefanidi, Emil Rudolf. Silencing of E-cadherin expression leads to increased chemosensitivity to irinotecan and oxaliplatin in colorectal cancer cell linesHuman & Experimental Toxicology 2021; 40(12) doi: 10.1177/09603271211021479